Results from the 2013 National Survey on Drug Use and Health:
Detailed Tables
Acknowledgments
These tables were prepared by the Center for Behavioral Health Statistics and Quality (CBHSQ), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services (HHS), and by RTI International, a trade name of Research Triangle Institute, Research Triangle Park, North Carolina. Work by RTI was performed under Contract No. HHSS283201000003C. Contributors and reviewers at RTI listed alphabetically include Jeremy Aldworth, Katherine J. Asman, Stephanie N. Barnett, Ellen Bishop, Michael R. Bradshaw, Lisa A. Carpenter, Pinliang (Patrick) Chen, Chuchun Chien, James R. Chromy, Elizabeth Copello, Devon S. Cribb, Lanting Dai, Christine Davies, Teresa R. Davis, Susan L. Edwards, Barbara J. Felts, Misty S. Foster, Peter A. Frechtel, Julia M. Gable, Gina S. Geercken, Harper Gordek, Rebecca A. Granger, Kristen Gulledge, Wafa Handley, Erica L. Hirsch, David Hunter (Project Director), Phillip S. Kott, Larry A. Kroutil, Jeffrey S. Laufenberg, Philip K. Lee, Dan Liao, Peilan Chen Martin, Andrew S. Moore, Lisa E. Packer, Michael R. Pemberton, Brenda K. Porter, Jeremy D. Porter, Rosanna S. Quiroz, Harley F. Rohloff, Jessica Roycroft, Neeraja S. Sathe, Jennifer H. Schoden, Kathryn Spagnola, Jiantong (Jean) Wang, Lauren K. Warren, Matthew J. Westlake, Cherie J. Winder, and Carol L. Woodell. Contributors at SAMHSA listed alphabetically include Peggy Barker (contractor), Jonaki Bose, Kathryn Downey, Beth Han, Sarra L. Hedden, Arthur Hughes, Joel Kennet, Rachel Lipari, Pradip Muhuri, Grace E. O'Neill, Dicy Painter, and Peter Tice (Project Officer). At RTI, Farrah Bullock Mann and Brenda K. Porter formatted the tables; Melissa H. Hargraves, Laura James, Amber M. Rohloff, Margaret A. Smith, and Richard S. Straw provided editorial assistance; and Teresa F. Bass, Debbie F. Bond, Kimberly H. Cone, Valerie Garner, Daniel Occoquan, Pamela Couch Prevatt, Roxanne Snaauw, Pamela Tuck, and Cheryl L. Velez provided Web conversion and/or document production support.
Results from the 2013 National Survey on Drug Use and Health: Detailed Tables is a collection of tables presenting national estimates from the National Survey on Drug Use and Health (NSDUH). These tables present information on drug, alcohol, and tobacco use, as well as drug and alcohol dependence and abuse and treatment. Measures of these behaviors and characteristics are presented by a variety of demographic, geographic, and other variables. The estimates in the tables include rates of the behaviors, numbers of persons engaging in these behaviors, and other measures.
Although the majority of these tables are trend tables presenting estimates from the 2012 and 2013 NSDUHs, some tables include only estimates from the 2013 NSDUH. Also, a number of tables contain annual averages that are generated by combining multiple years of data if sufficient data within a single year are unavailable to produce reliable estimates. These tables may provide annual averages combining data for (a) 2012 and 2013; (b) 2010 and 2011; and (c) 2010, 2011, 2012, and 2013. Also included are a number of tables that present data from earlier surveys in the series, including a section of tables presenting data mainly from 2002 to 2013 and a couple of tables within that section presenting data from 1971 to 2013.
Because of survey improvements in the 2002 NSDUH, the 2002 data constitute a new baseline for tracking trends in substance use and other measures. Therefore, estimates from the 2002 through 2013 surveys should not be compared with estimates from the 2001 or earlier surveys to examine changes over time. Methodology changes throughout NSDUH's history make it difficult to assess long-term trends from tables presenting data from 1971 to 2013. However, it is instructive to compare NSDUH estimates from 1971 to 2013 by "piecing together" the data from time periods for which data are comparable. Specifically, valid trend comparisons can be made for 1971-1998, 1999-2001, and 2002-2013. With this approach, comparisons between 1998 and 1999, and between 2001 and 2002, should be made with caution because they are potentially biased due to changes in methods. Nevertheless, when these data are combined in a single presentation, it often becomes clear that the effects of the changes in methods are small compared with the major shifts in substance use prevalence that have occurred over the past four decades.
A description of the survey measurement issues and the sample design and estimation procedures used in the 2013 NSDUH can be found in technical appendices of the Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings.1 Definitions for many of the measures and terms used in these detailed tables and in the national findings report can be located in the Key Definitions for the 2013 Detailed Tables and National Findings Report (i.e., the glossary) that is provided with these detailed tables.2 Where relevant, the glossary provides cross-references between terms and specific question wording for clarity.
Tables presenting the prevalence of mental health problems, related treatment, and the co-occurrence of substance use and mental health problems will be released separately as the Results from the 2013 National Survey on Drug Use and Health: Mental Health Detailed Tables. This set of tables and a report on Results from the 2013 National Survey on Drug Use and Health: Mental Health Findings are scheduled to be made available in November 2014.
Table Revisions
During regular data collection and processing checks for the 2011 NSDUH, data errors were identified. These errors affected the data for Pennsylvania (2006-2010) and Maryland (2008-2009). Cases with erroneous data were removed from the data files, and the remaining cases were reweighted to provide representative estimates. The errors had minimal impact on the national estimates and no effect on direct estimates for the other 48 States and the District of Columbia. In reports where model-based small area estimation techniques are used, estimates for all States may be affected, even though the errors were concentrated in only two States. In reports that do not use model-based estimates, the only estimates appreciably affected are estimates for Pennsylvania, Maryland, the mid-Atlantic division, and the Northeast region.
The 2013 detailed tables and 2013 national findings report do not include State-level or model-based estimates. However, they do include estimates for the mid-Atlantic division and the Northeast region. Estimates based on 2006-2010 data may differ from previously published estimates. Tables and estimates based only on data since 2011 are unaffected by these data errors. All affected tables (i.e., tables with estimates based on 2006-2010 data) contain a note to indicate this to the user.
Caution is advised when comparing data from older reports with data from more recent reports that are based on corrected data files. As discussed above, comparisons of estimates for Pennsylvania, Maryland, the mid-Atlantic division, and the Northeast region are of most concern, while comparisons of national data or data for other States and regions are essentially still valid. The Center for Behavioral Health Statistics and Quality within the Substance Abuse and Mental Health Services Administration does not recommend making comparisons between unrevised 2006-2010 estimates and estimates based on data for 2011 and subsequent years for the areas of greatest concern.
Table Numbering
The detailed tables are numbered using a three-part numbering scheme (e.g., 1.15A). The first part of the table number (1.15A) is the subject matter section to which a particular table belongs. The second part (1.15A) is the number of the table within a particular section. The third part (1.15A) is a table type indicator, an alphabetic letter appended to the table number. Each table number, as explained below, has multiple table types. Tables are numbered sequentially within each subject matter section. To the extent possible, identical tables are assigned the same table number each year except in the case where specific tables are removed or added.
The eight subject matter sections and the number of tables per section are as follows:
Section 1: Illicit Drug Use Tables - 1.1 to 1.92
Section 2: Tobacco Product and Alcohol Use Tables - 2.1 to 2.84
Section 3: Risk and Protective Factor Tables - 3.1 to 3.25
Section 4: Incidence Tables - 4.1 to 4.16
Section 5: Dependence, Abuse, and Treatment Tables - 5.1 to 5.56
Section 6: Miscellaneous Tables - 6.1 to 6.107
Section 7: Trend Tables - 7.1 to 7.45
Section 8: Sample Size and Population Tables - 8.1 to 8.13
The table type indicators are primarily defined as follows; however, some exceptions do exist and are noted in subsequent bullets.
Table Type
Purpose of the Table
A:
Presents estimates of the numbers of persons exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings.
B:
Presents estimates of the percentages of persons exhibiting the specified behavior or characteristic (e.g., substance use) in the populations described by the column and row headings.
C:
Presents the standard error associated with each of the estimates in the "A" tables.
D:
Presents the standard error associated with each of the estimates in the "B" tables.
N:
Presents the number of cases in the specified NSDUH sample with the characteristics defined by the column and row headings.
P:
Presents the p values from tests of the statistical significance of differences between columns in the "B" tables.
The majority of tables within the detailed tables contain five table types (A, B, C, D, and P) as defined above. Note that table type N is used exclusively within Section 8 to display the sample size counts. Exceptions to this organization are noted as follows:
Section 3 (Risk and Protective Factor Tables) includes tables for which only table types A, B, C, and D are produced (Tables 3.19 to 3.25). These tables present estimates for the 2013 NSDUH only; thus, these are not trend tables, so significance tests between years are not relevant and table type P is not applicable.
Section 4 (Incidence Tables) contains both tables for which only table types A and C are produced and tables for which only table types B, D, and P are produced. Specifically, one subset of tables (Tables 4.9 to 4.12) includes table types A and C. This subset of tables presents the number of past year initiates in table type A and the associated standard errors in table type C. The remaining Section 4 tables include only table types B, D, and P. Tables 4.1 to 4.8 present numbers and percentages of past year initiates in table type B, associated standard errors for each of these estimates in table type D, and p values from tests of statistical differences between years in table type P. Tables 4.13 to 4.16 present the mean age for past year initiates in table type B, associated standard errors in table type D, and p values from tests of statistical differences between years in table type P.
Section 5 (Dependence, Abuse, and Treatment Tables) includes tables for which only table types A, B, C, and D are produced (Tables 5.54 to 5.56). These tables present annual averages based on combined 2010-2013 NSDUH data; thus, these are not trend tables, so significance tests between years are not relevant and table type P is not applicable.
Section 7 (Trend Tables) contains one subset of tables for which only table types B and D are produced and one subset of tables for which only table types B, D, and P are produced. Specifically, one subset of tables (Tables 7.44 and 7.45) are multiyear tables that present estimated percentages for 1971 to 2013 in table type B and associated standard errors in table type D. The estimated total number of users and associated standard errors are not presented, nor are between-year significance tests implemented; thus, table types A, C, and P are not used. The other subset of tables (Tables 7.38 and 7.39) are multiyear tables that include only table types B, D, and P. Tables 7.38 and 7.39 present the number of past year initiates, percentages of past year initiates, and the mean age for past year initiates in table type B, associated standard errors for each of these estimates in table type D, and p values from tests of statistical differences between years in table type P.
Section 8 (Sample Size and Population Tables) contains only table types A, C, and N. Population counts, standard errors, and sample sizes are displayed in table types A, C, and N, respectively. Percentages of the population and associated standard error tables are not provided in this section.
Locating a Table
The detailed tables are organized by table type into two categories:
Prevalence Estimates and Sample Sizes - Table Types A, B, and N
Standard Errors and P Values - Table Types C, D, and P
Both categories are organized based on eight subject matter sections as listed below. Clicking on the subject matter section of interest takes users to a list of tables for that section. Users can scroll through the list of table titles to find the table of interest, then click on the table title to go directly to that table. Users need to return to the table of contents to access tables from other sections or categories.
The Key Definitions for the 2013 Detailed Tables and National Findings Report (i.e., the glossary) defines and cross-references key measures used in the 2013 detailed tables and the 2013 national findings report. This may be helpful when used in conjunction with the list of tables in identifying tables that contain information for selected measures. However, not all measures and terms listed in the glossary are specifically mentioned in the table index or list of tables.
The eight subject matter sections are as follows:
Section 1: Illicit Drug Use Tables - 1.1 to 1.92
Section 2: Tobacco Product and Alcohol Use Tables - 2.1 to 2.84
Section 3: Risk and Protective Factor Tables - 3.1 to 3.25
Section 4: Incidence Tables - 4.1 to 4.16
Section 5: Dependence, Abuse, and Treatment Tables - 5.1 to 5.56
Section 6: Miscellaneous Tables - 6.1 to 6.107
Section 7: Trend Tables - 7.1 to 7.45
Section 8: Sample Size and Population Tables- 8.1 to 8.13
To print a PDF document, find and click on the print icon of your browser's document window (its placement varies depending on browser type and browser version). Alternatively, select File from your browser's pull-down menu and choose Print.
From the print dialog window, be sure to specify whether you want to print the current page, a selected range of pages, or the entire document. If you do not indicate differently, all the pages in the file will print. Your Zoom In tool (e.g., sometimes shown as a magnifying glass with a plus sign inside) can be used to enlarge the screen text size at any time.
Key Definitions for the 2013 Detailed Tables and National Findings Report
This glossary provides definitions for many of the measures and terms used in these tables and in the national findings report1 from the 2013 National Survey on Drug Use and Health (NSDUH). Where relevant, cross-references also are provided. For some key terms, specific question wording is provided for clarity. In some situations, information also is included about specific gate questions. In many instances, a gate question is the first question in a series of related questions. How a respondent answers the gate question affects whether the respondent is asked additional questions in that section of the interview or is routed to the next section of the interview. In some sections of the interview, respondents may be asked more than one gate question to determine whether they are asked additional questions in that section or are routed to the next section.
Abuse
NSDUH questions about abuse ask about the following symptoms, consistent with the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)2: (1) problems at work, home, and school; (2) doing something physically dangerous; (3) repeated trouble with the law; and (4) problems with family or friends because of use of alcohol or illicit drugs in the past 12 months. Respondents meet criteria for abuse if they report one or more of these symptoms and if the criteria for dependence were not met for that substance. Respondents were asked the abuse questions for illicit drugs other than marijuana if they reported any use in the past 12 months. Respondents were asked the alcohol and marijuana abuse questions if they indicated use of these substances on 6 or more days in the past 12 months. These questions for measuring abuse for illicit drugs or alcohol have been included in the survey since 2000. Responses to the dependence or abuse questions based only on the past year use of methamphetamine, Ambien®, Adderall®, or specific hallucinogens from the noncore special drugs module were not included in these abuse and dependence measures to maintain the comparability of estimates over time.
SEE: "Dependence," "Illicit Drugs," "Need for Illicit Drug or Alcohol Use Treatment," "Noncore," and "Prevalence."
ACASI
ACASI stands for audio computer-assisted self-interviewing. ACASI questions in NSDUH appear on a laptop computer screen while an audio recording of the questions plays on headphones. Respondents enter their answers directly into the computer. ACASI is designed to provide the respondent with a highly private and confidential mode for responding to questions about illicit drug use and other sensitive behaviors. The audio also is helpful for respondents with limited reading skill.
SEE: "CAPI," "Core," and "Noncore."
Adderall® Use
Measures of use of the prescription stimulant Adderall® in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "Earlier, the computer recorded that you have used Adderall that was not prescribed for you or that you took only for the experience or feeling it caused. How long has it been since you last used Adderall in either of these ways?" The questions about Adderall® were added to a noncore section of the interview in 2006 and were not incorporated in estimates of use of stimulants, nonmedical use of psychotherapeutics, or other estimates of illicit drug use because inclusion of these questions would affect the comparability of estimates over time.
SEE: "Core," "Current Use," "Illicit Drugs," "Illicit Drugs Other Than Marijuana," "Lifetime Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," and "Stimulant Use."
Age
Age of the respondent was defined as "age at time of interview." The interview program calculated the respondent's age from the interview date and the date of birth that was reported to the interviewer. The interview program prompts the interviewer to confirm the respondent's age after it has been calculated.
Alcohol Use
Measures of use of alcohol in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last drank an alcoholic beverage?" The question about recency of use was asked if respondents previously reported any use of alcohol in their lifetime.
The following definitional information preceded the question about lifetime alcohol use: "The next questions are about alcoholic beverages, such as, beer, wine, brandy, and mixed drinks. Listed on the next screen are examples of the types of beverages we are interested in. Please review this list carefully before you answer these questions. These questions are about drinks of alcoholic beverages. Throughout these questions, by a 'drink,' we mean a can or bottle of beer, a glass of wine or a wine cooler, a shot of liquor, or a mixed drink with liquor in it. We are not asking about times when you only had a sip or two from a drink."
SEE: "Binge Use of Alcohol," "Current Use," "Heavy Use of Alcohol," "Lifetime Use," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," and "Underage Alcohol Use."
Alcohol Use in Combination with Illicit Drug Use
A respondent was defined as having alcohol use in combination with illicit drug use if he or she reported using 1 or more of 10 possible illicit drugs with his or her last alcohol use or within a couple of hours of drinking. Respondents who used alcohol and also used illicit drugs in the past month were asked about this behavior. The illicit drugs that respondents could have used in combination with alcohol were marijuana or hashish, cocaine or crack, heroin, hallucinogens, inhalants, prescription pain relievers, prescription tranquilizers, prescription stimulants, methamphetamine, or prescription sedatives.
NOTE: Respondents were defined as having used methamphetamine with their most recent use of alcohol in the past month if they reported methamphetamine use in the core stimulants module. They also were included if they reported methamphetamine use in the noncore special drugs module and said they had not reported methamphetamine use in the core module because they did not think of it as a prescription drug.
SEE: "Alcohol Use," "Core," "Illicit Drugs," "Methamphetamine Use," and "Noncore."
Ambien® Use
Measures of use of the prescription sedative Ambien® in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "Earlier, the computer recorded that you have used Ambien that was not prescribed for you or that you took only for the experience or feeling it caused. How long has it been since you last used Ambien in either of these ways?" The questions about Ambien® use were added to a noncore section of the interview in 2006 and were not incorporated in estimates of use of sedatives, nonmedical use of psychotherapeutics, or other estimates of illicit drug use because inclusion of these questions would affect the comparability of estimates over time.
SEE: "Core," "Current Use," "Illicit Drugs," "Illicit Drugs Other Than Marijuana," "Lifetime Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," and "Sedative Use."
American Indian or Alaska Native
American Indian or Alaska Native only, not of Hispanic, Latino, or Spanish origin including North American, Central American, or South American Indian. This does not include respondents reporting two or more races. Respondents reporting that they were American Indians or Alaska Natives and of Hispanic, Latino, or Spanish origin were classified as Hispanic.
SEE: "Hispanic," "Race/Ethnicity," and "Two or More Races."
Asian
Asian only, not of Hispanic, Latino, or Spanish origin. This does not include respondents reporting two or more races. Respondents reporting that they were Asian and of Hispanic, Latino, or Spanish origin were classified as Hispanic. Specific Asian groups that were asked about were Asian Indian, Chinese, Filipino, Japanese, Korean, Vietnamese, and "Other Asian."
SEE: "Hispanic," "Race/Ethnicity," and "Two or More Races."
Binge Use of Alcohol
Binge use of alcohol was defined for both males and females as drinking five or more drinks on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past 30 days. Respondents were asked about the number of days they had five or more drinks on the same occasion if they reported last using any alcohol in the past 30 days based on the following question: "How long has it been since you last drank an alcoholic beverage?"
SEE: "Alcohol Use" and "Heavy Use of Alcohol."
Black
Black/African American only, not of Hispanic, Latino, or Spanish origin. This does not include respondents reporting two or more races. Respondents reporting that they were black or African American and of Hispanic, Latino, or Spanish origin were classified as Hispanic.
SEE: "Hispanic," "Race/Ethnicity," and "Two or More Races."
Blunts
Blunts were defined as cigars with marijuana in them. Measures of the use of blunts in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "How long has it been since you last smoked part or all of a cigar with marijuana in it?" The question about recency of use was asked if respondents previously reported any use of cigars with marijuana in them in their lifetime.
The following definitional information preceded the question about lifetime use of cigars with marijuana in them: "Sometimes people take tobacco out of a cigar and replace it with marijuana. This is sometimes called a 'blunt.'"
SEE: "Cigar Use," "Core," "Current Use," "Lifetime Use," "Marijuana Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," and "Tobacco Product Use."
CAPI
CAPI stands for computer-assisted personal interviewing. CAPI questions in NSDUH are interviewer administered. Interviewers read these questions to respondents, then enter the respondents' answers into a laptop computer.
SEE: "ACASI," "Core," and "Noncore."
Cigar Use
Measures of use of cigars, including big cigars, cigarillos, and little cigars that look like cigarettes, in the respondent's lifetime, the past year, and the past month were derived from responses to the questions about cigar use in the past 30 days and the recency of use (if not in the past 30 days): "Now think about the past 30 days—that is, from [DATEFILL] up to and including today. During the past 30 days, have you smoked part or all of any type of cigar?" and "How long has it been since you last smoked part or all of any type of cigar?" Responses to noncore questions about use of cigars with marijuana in them (blunts) were not included in these measures to maintain the comparability of estimates over time. Questions about use of cigars in the past 30 days or the most recent use of cigars (if not in the past 30 days) were asked if respondents previously reported any use of cigars in their lifetime.
SEE: "Blunts," "Cigarette Use," "Core," "Current Use," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," "Smokeless Tobacco Use," and "Tobacco Product Use."
Cigarette Use
Measures of use of cigarettes in the respondent's lifetime, the past year, and the past month were derived from responses to the questions about cigarette use in the past 30 days and the recency of use (if not in the past 30 days): "Now think about the past 30 days—that is, from [DATEFILL] up to and including today. During the past 30 days, have you smoked part or all of a cigarette?" and "How long has it been since you last smoked part or all of a cigarette?" Questions about use of cigarettes in the past 30 days or the most recent use of cigarettes (if not in the past 30 days) were asked if respondents previously reported that they smoked part or all of a cigarette in their lifetime.
Measures of use of cocaine, including powder, crack, free base, and coca paste, in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used any form of cocaine?" The question about recency of use was asked if respondents previously reported any use of cocaine in their lifetime.
SEE: "Crack Use," "Current Use," "Lifetime Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
College Enrollment Status
This measure was developed only for college-aged respondents aged 18 to 22 based on answers to questions about current or upcoming enrollment in school, and (if applicable) whether respondents were full- or part-time students, and the grade that they were or will be attending. Respondents in this age group were classified either as full-time college students or as some other status, which included respondents not enrolled in school, enrolled in college part time, enrolled in other grades either full time or part time, or enrolled with no other information available. Respondents were classified as full-time college students if they reported that they were attending or will be attending their first through fifth or higher year of college or university and that they were or will be a full-time student. Respondents whose current enrollment status was unknown were excluded from this measure.
Core
The NSDUH interview includes two types of sections or modules: (a) core and (b) noncore. A core set of questions critical for basic trend measurement of prevalence estimates remains relatively unchanged in the survey every year and is contained in the first part of the interview. The core consists of initial interviewer-administered demographic items (administered through computer-assisted personal interviewing [CAPI]) and self-administered questions (administered through audio computer-assisted self-interviewing [ACASI]) pertaining to the use of tobacco, alcohol, marijuana, cocaine, crack cocaine, heroin, hallucinogens, inhalants, prescription pain relievers, prescription tranquilizers, prescription stimulants, and prescription sedatives. Noncore questions, or modules, can be revised, dropped, or added from year to year and make up the latter part of the interview.
SEE: "ACASI," "CAPI," and "Noncore."
County Type
County type is based on the "Rural/Urban Continuum Codes" developed in 2003 by the U.S. Department of Agriculture.3 All U.S. counties and county equivalents were grouped based on revised definitions of metropolitan statistical areas (MSAs) and definitions of micropolitan statistical areas as defined by the Office of Management and Budget in June 2003.4 Large MSAs (large metro) have a total population of 1 million or more. Small MSAs (small metro) have a total population of fewer than 1 million. Nonmetropolitan (nonmetro) areas include counties in micropolitan statistical areas as well as counties outside of both metropolitan and micropolitan statistical areas. Nonmetro counties with a population of 20,000 or more in urbanized areas are classified as "urbanized," nonmetro counties with a population of at least 2,500 but fewer than 20,000 in urbanized areas are classified as "less urbanized," and nonmetro counties with a population of fewer than 2,500 in urbanized areas are classified as "completely rural." The terms "urbanized," "less urbanized," and "completely rural" for counties are not based on the relative proportion of the county population in urbanized areas, but rather on the absolute size of the population in urbanized areas. For example, some counties classified as "less urbanized" had over 50 percent of the county population residing in urbanized areas, but this represented fewer than 20,000 people in the county. Population counts used are from the 2000 census representing the resident population.
Crack Use
Crack is defined as cocaine that is used in rock or chunk form. Measures of use of crack cocaine in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used crack?" The question about recency of use was asked if respondents previously reported use of cocaine in any form and specifically any use of crack in their lifetime. Respondents who reported that they never used any form of cocaine were logically defined as never having used crack.
SEE: "Cocaine Use," "Current Use," "Lifetime Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Current Use
Any reported use of a specific substance in the past 30 days (also referred to as past month use).
SEE: "Lifetime Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Delinquent Behavior
Youths aged 12 to 17 were asked a series of six questions: "During the past 12 months, how many times have you … gotten into a serious fight at school or work?" "taken part in a fight where a group of your friends fought against another group?" "carried a handgun?" "sold illegal drugs?" "stolen or tried to steal anything worth more than $50?" and "attacked someone with the intent to seriously hurt them?" Response options were (1) 0 times, (2) 1 or 2 times, (3) 3 to 5 times, (4) 6 to 9 times, or (5) 10 or more times. Respondents were defined as having engaged in a specific delinquent behavior if they reported engaging in that behavior at least one time in the past 12 months.
SEE: "Prevalence."
Dependence
NSDUH substance dependence questions ask about the following symptoms, consistent with the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)5: (1) spending a lot of time engaging in activities related to substance use; (2) using the substance in greater quantities or for a longer time than intended; (3) tolerance (i.e., needing to use the substance more than before to get desired effects or noticing that the same amount of substance use had less effect than before); (4) unsuccessful attempts to cut down on use; (5) continued substance use despite physical health or emotional problems associated with substance use; (6) reducing or eliminating participation in other activities because of substance use; and (7) withdrawal symptoms. For the specific illicit drugs and alcohol that include a withdrawal criterion as one of the criteria that can be used to establish dependence, respondents meet the criteria for dependence if they met three out of the seven criteria. For illicit drugs that do not include a withdrawal criterion to establish dependence, respondents meet the criteria for dependence if they met three out of the six criteria for that substance. Respondents were asked the dependence questions for illicit drugs other than marijuana if they reported any use in the past 12 months. Respondents were asked the alcohol and marijuana dependence questions only if they indicated use of these substances on 6 or more days in the past 12 months. These criteria were not used to define nicotine (cigarette) dependence, which used a different series of items. Responses to the dependence or abuse questions based only on the past year use of methamphetamine, Ambien®, Adderall®, or specific hallucinogens from the noncore special drugs module were not included in these measures.
SEE: "Abuse," "Need for Alcohol Use Treatment," "Need for Illicit Drug or Alcohol Use Treatment," "Need for Illicit Drug Use Treatment," "Nicotine (Cigarette) Dependence," "Noncore," and "Prevalence."
DMT, AMT, or 5-MeO-DIPT ("Foxy") Use
Measures of use of dimethyltryptamine (DMT), alpha-methyltryptamine (AMT), or N, N-diisopropyl-5-methoxytryptamine (5-MeO-DIPT or "Foxy") in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "Earlier, the computer recorded that you have used DMT, AMT, or Foxy. How long has it been since you last used any of these drugs?" The questions about DMT, AMT, or 5-MeO-DIPT were added to a noncore section of the interview in 2006 and were not incorporated in estimates of use of hallucinogens, illicit drugs, or illicit drugs other than marijuana because inclusion of these questions would affect the comparability of estimates over time.
SEE: "Core," "Current Use," "Hallucinogen Use," "Illicit Drugs," "Illicit Drugs Other Than Marijuana," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Driving Under the Influence
Respondents who reported use of alcohol or illicit drugs in the past 12 months were asked up to three questions in a noncore section of the interview about driving a vehicle in the past 12 months while under the influence of (a) alcohol and illegal drugs used together, (b) alcohol only, or (c) illegal drugs only. Respondents were defined as driving under the influence of illicit drugs if they reported driving under the influence of alcohol and illegal drugs used together or illegal drugs only. Respondents were defined as driving under the influence of alcohol if they reported driving under the influence of alcohol and illegal drugs used together or alcohol only. Respondents were defined as driving under the influence of illicit drugs or alcohol if they reported driving under the influence in response to any of these three questions.
SEE: "Core," "Illicit Drugs," "Noncore," and "Prevalence."
Ecstasy Use
Measures of use of Ecstasy or MDMA (methylenedioxy-methamphetamine) in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used Ecstasy, also known as MDMA?" The question about recency of use was asked if respondents previously reported any use of Ecstasy or MDMA in their lifetime.
SEE: "Current Use," "Hallucinogen Use," "Lifetime Use," "LSD Use," "Past Month Use," "Past Year Use," "PCP Use," "Prevalence," and "Recency of Use."
Education
This is the measure of educational attainment among respondents who are aged 18 or older. It is based on respondents' reports of their highest grade or year of school that they completed. Response options were presented in terms of single years of education, ranging from 0 if respondents never attended school to 17 if respondents completed 5 or more years at the college or university level. Respondents were classified into four categories based on their answers: less than high school, high school graduate, some college, and college graduate. Persons indicating having completed the 12th grade were classified as high school graduates, and persons who indicated completing 4 or more years at the college or university level were defined as being college graduates.
Employment
Respondents were asked to report whether they worked in the week prior to the interview, and if not, whether they had a job despite not working in the past week. Respondents who worked in the past week or who reported having a job despite not working were asked whether they usually work 35 or more hours per week. Respondents who did not work in the past week but had a job were asked to look at a card that described why they did not work in the past week despite having a job. Respondents who did not have a job in the past week were asked to look at a different card that described why they did not have a job in the past week.
Full-time
"Full-time" includes respondents who usually work 35 or more hours per week and who worked in the past week or had a job despite not working in the past week.
Part-time
"Part-time" includes respondents who usually work fewer than 35 hours per week and who worked in the past week or had a job despite not working in the past week.
Unemployed
"Unemployed" refers to respondents who did not have a job and were looking for work or who were on layoff. For consistency with the Current Population Survey definition of unemployment, respondents who reported that they did not have a job but were looking for work needed to report making specific efforts to find work in the past 30 days, such as sending out resumes or applications, placing ads, or answering ads.
Other
"Other" includes all responses defined as not being in the labor force, including being a student, keeping house or caring for children full time, retired, disabled, or other miscellaneous work statuses. Respondents who reported that they did not have a job and did not want one also were classified as not being in the labor force. Similarly, respondents who reported not having a job and looking for work also were classified as not being in the labor force if they did not report making specific efforts to find work in the past 30 days. Those respondents who reported having no job and provided no additional information could not have their labor force status determined and were therefore assigned to the "Other" employment category.
Ethnicity
SEE: "Race/Ethnicity."
Ever Used
SEE: "Lifetime Use."
Exposure to Drug Education and Prevention
The following measures were created for exposure to drug education and prevention among youths aged 12 to 17: (a) exposure to prevention messages in school; (b) participation in a prevention program outside of school; (c) seeing or hearing prevention messages from sources outside of school; and (d) conversations with parents about the dangers of substance use.
Youths who reported that they attended any type of school at any time in the past 12 months were asked: "During the past 12 months … Have you had a special class about drugs or alcohol in school?" "Have you had films, lectures, discussions, or printed information about drugs or alcohol in one of your regular classes, such as health or physical education?" "Have you had films, lectures, discussions, or printed information about drugs or alcohol outside of one of your regular classes, such as in a special assembly?" Youths who reported having had any of these were defined as having seen or heard prevention messages in school.
Youths who reported that they were home schooled in the past 12 months also were asked these questions. Youths who reported that they were home schooled were instructed to think about their home schooling as "school."
Youths also were asked: "During the past 12 months … Have you participated in an alcohol, tobacco or drug prevention program outside of school, where you learn about the dangers of using, and how to resist using, alcohol, tobacco, or drugs?" "Have you seen or heard any alcohol or drug prevention messages from sources outside school such as posters, pamphlets, radio, or TV?" "Have you talked with at least one of your parents about the dangers of tobacco, alcohol, or drug use?" Youths who answered these questions as "yes" were defined as having been exposed to prevention messages from these sources outside of school.
Family Income
Family income was estimated by asking respondents about their total personal income and total family income, based on the following questions: "Of these income groups, which category best represents (your/SAMPLE MEMBER's) total personal income during [the previous calendar year]?" and "Of these income groups, which category best represents (your/SAMPLE MEMBER's) total combined family income during [the previous calendar year]?" Family was defined as any related member in the household, including all foster relationships and unmarried partners (including same-sex partners). It excluded roommates, boarders, and other nonrelatives.
NOTE: If no other family members were living with the respondent, total family income was based on information about the respondent's total personal income. For youths aged 12 to 17 and those respondents who were unable to respond to the health insurance or income questions, proxy responses were accepted from a household member identified as being better able to give the correct information about health insurance and income.
Geographic Division
Data are presented for nine geographic divisions within the four geographic regions. Within the Northeast Region are the New England Division (Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont) and the Middle Atlantic Division (New Jersey, New York, Pennsylvania). Within the Midwest Region are the East North Central Division (Illinois, Indiana, Michigan, Ohio, Wisconsin) and the West North Central Division (Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota). Within the South Region are the South Atlantic Division (Delaware, District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia), the East South Central Division (Alabama, Kentucky, Mississippi, Tennessee), and the West South Central Division (Arkansas, Louisiana, Oklahoma, Texas). Within the West Region are the Mountain Division (Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming) and the Pacific Division (Alaska, California, Hawaii, Oregon, Washington).
SEE: "Region."
GHB Use
Measures of use of gamma hydroxybutyrate (GHB) in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "Earlier, the computer recorded that you have used GHB. How long has it been since you last used GHB?" The questions about GHB were added to a noncore section of the interview in 2006 and were not incorporated in estimates of use of illicit drugs or illicit drugs other than marijuana because inclusion of these questions would affect the comparability of estimates over time.
The following definitional information preceded the question about lifetime use of GHB: "The next question is about GHB, also called G, Georgia Home Boy, Grievous Bodily Harm, Liquid G, or gamma hydroxybutyrate."
SEE: "Core," "Current Use," "Illicit Drugs," "Illicit Drugs Other Than Marijuana," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Hallucinogen Use
Measures of use of hallucinogens in the respondent's lifetime, the past year, and the past month were derived from responses to the core question about recency of use: "How long has it been since you last used any hallucinogen?" The question about recency of use was asked if respondents previously reported any use of hallucinogens in their lifetime. Responses to noncore questions about the use of the following drugs, which were added to the survey in 2006, were not included in these measures: ketamine, DMT (dimethyltryptamine), AMT (alpha-methyltryptamine), 5-MeO-DIPT (N, N-diisopropyl-5-methoxytryptamine, also known as "Foxy"), and Salvia divinorum.
Respondents were asked a series of gate questions about any use of specific hallucinogens in their lifetime. These gate questions were preceded by the following definitional information about hallucinogens: "The next questions are about substances called hallucinogens. These drugs often cause people to see or experience things that are not real."
Gate questions asked whether respondents ever used the following hallucinogens, even once: (a) LSD, also called "acid"; (b) PCP, also called "angel dust" or phencyclidine; (c) peyote; (d) mescaline; (e) psilocybin, found in mushrooms; (f) "Ecstasy," also known as MDMA; and (g) any other hallucinogen besides the ones that have been listed.
SEE: "Core," "Current Use," "Ecstasy Use," "Lifetime Use," "LSD Use," "Noncore," "Past Month Use," "Past Year Use," "PCP Use," "Prevalence," and "Recency of Use."
Heavy Use of Alcohol
Heavy use of alcohol was defined for both males and females as drinking five or more drinks on the same occasion (i.e., at the same time or within a couple of hours of each other) on each of 5 or more days in the past 30 days. Heavy alcohol users also were defined as binge users of alcohol. Respondents were asked about the number of days they had five or more drinks on the same occasion if they reported last using any alcohol in the past 30 days based on the following question: "How long has it been since you last drank an alcoholic beverage?"
SEE: "Alcohol Use" and "Binge Use of Alcohol."
Heroin Use
Measures of use of heroin in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used heroin?" The question about recency of use was asked if respondents previously reported any use of heroin in their lifetime.
SEE: "Current Use," "Lifetime Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Hispanic
Hispanic was defined as anyone of Hispanic, Latino, or Spanish origin. Respondents were classified as Hispanic in the race/ethnicity measure regardless of race.
SEE: "American Indian or Alaska Native," "Asian," "Black," "Native Hawaiian or Other Pacific Islander," "Race/Ethnicity," "Two or More Races," and "White."
Illicit Drugs
Illicit drugs include marijuana or hashish, cocaine (including crack), heroin, hallucinogens (including phencyclidine [PCP], lysergic acid diethylamide [LSD], and Ecstasy [MDMA]), inhalants, or prescription-type psychotherapeutics used nonmedically, which include pain relievers, tranquilizers, stimulants, and sedatives. Illicit drug use refers to use of any of these drugs based on responses to questions only in the core sections and does not include data from the noncore methamphetamine items that were added in 2005 and 2006. Responses to questions about the use of the following drugs, which have been included in the survey since 2006, also were not included in these measures: GHB (gamma hydroxybutyrate), Adderall®, Ambien®, nonprescription cough or cold medicines, ketamine, DMT (dimethyltryptamine), AMT (alpha-methyltryptamine), 5-MeO-DIPT (N, N-diisopropyl-5-methoxytryptamine, also known as "Foxy"), and Salvia divinorum.
SEE: "Core," "Current Use," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," "Psychotherapeutic Drugs," and "Recency of Use."
Illicit Drugs Other Than Marijuana
These drugs include cocaine (including crack), heroin, hallucinogens (including phencyclidine [PCP], lysergic acid diethylamide [LSD], and Ecstasy [MDMA]), inhalants, or prescription-type psychotherapeutics used nonmedically, which include pain relievers, tranquilizers, stimulants, and sedatives. This measure includes marijuana users who used any of the above drugs in addition to using marijuana, as well as users of those drugs who have not used marijuana. The measure for illicit drugs other than marijuana is defined based on responses to questions only in the core sections and does not include responses based on the noncore methamphetamine items that were added in 2005 and 2006. Responses to questions about the use of the following drugs, which have been included in the survey since 2006, also were not included in these measures: GHB (gamma hydroxybutyrate), Adderall®, Ambien®, nonprescription cough or cold medicines, ketamine, DMT (dimethyltryptamine), AMT (alpha-methyltryptamine), and 5-MeO-DIPT (N, N-diisopropyl-5-methoxytryptamine, also known as "Foxy"), and Salvia divinorum.
SEE: "Core," "Current Use," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," "Psychotherapeutic Drugs," and "Recency of Use."
Incidence
Substance use incidence refers to the use of a substance for the first time (new use). Incidence statistics in NSDUH reflect first use occurring within the 12 months prior to the interview. This is referred to as past year incidence.
Incidence estimates are based on questions about age at first use of substances, year and month of first use for recent initiates, the respondent's date of birth, and the interview date. For these estimates, respondents who are immigrants are included regardless of whether their first use occurred inside or outside the United States. See Section B.4.1 in Appendix B of the 2013 national findings report for additional details.6
SEE: "Prevalence."
Income
SEE: "Family Income."
Inhalant Use
Measures of use of inhalants in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used any inhalant for kicks or to get high?" The question about recency of use was asked if respondents previously reported any use of inhalants in their lifetime.
Respondents were asked a series of gate questions about any use of specific inhalants in their lifetime. These gate questions were preceded by the following definitional information about inhalants: "These next questions are about liquids, sprays, and gases that people sniff or inhale to get high or to make them feel good. We are not interested in times when you inhaled a substance accidentally — such as when painting, cleaning an oven, or filling a car with gasoline."
Gate questions asked whether respondents ever inhaled the following substances, even once, for kicks or to get high: (a) amyl nitrite, "poppers," locker room odorizers, or "rush"; (b) correction fluid, degreaser, or cleaning fluid; (c) gasoline or lighter fluid; (d) glue, shoe polish, or toluene; (e) halothane, ether, or other anesthetics; (f) lacquer thinner or other paint solvents; (g) lighter gases, such as butane or propane; (h) nitrous oxide or "whippits"; (i) spray paints; (j) some other aerosol spray; and (k) any other inhalants besides the ones that have been listed.
SEE: "Current Use," "Lifetime Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Ketamine Use
Measures of use of ketamine in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "Earlier, the computer recorded that you have used Ketamine. How long has it been since you last used Ketamine?" The question about lifetime use of ketamine noted that ketamine also is called "Special K" or "Super K." The questions about ketamine were added to a noncore section of the interview in 2006 and were not incorporated in estimates of use of hallucinogens, illicit drugs, or illicit drugs other than marijuana because inclusion of these questions would affect the comparability of estimates over time.
SEE: "Core," "Current Use," "Hallucinogen Use," "Illicit Drugs," "Illicit Drugs Other Than Marijuana," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Large Metro
SEE: "County Type."
Lifetime Use
Lifetime use indicates use of a specific substance at least once in the respondent's lifetime. This measure includes respondents who also reported last using the substance in the past 30 days or past 12 months.
SEE: "Current Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Location of Most Recent Underage Alcohol Use
Respondents aged 12 to 20 who reported drinking at least one alcoholic beverage within the past 30 days were asked to indicate where they drank alcoholic beverages the last time they drank. The possible locations were (1) in a car or other vehicle; (2) at the respondent's home; (3) at someone else's home; (4) at a park, on a beach, or in a parking lot; (5) in a restaurant, bar, or club; (6) at a concert or sports game; (7) at school; or (8) some other place. Those who reported "some other place" were asked to write in a response indicating the specific location.
SEE: "Alcohol Use" and "Underage Alcohol Use."
Low Precision
Prevalence estimates based on a relatively small number of respondents or with relatively large standard errors were not shown in the tables, but have been replaced with an asterisk (*) and noted as "low precision." These estimates have been omitted because one cannot place a high degree of confidence in their accuracy. Table B.2 in Appendix B of the 2013 national findings report includes a complete list of the rules used to determine low precision.7
LSD Use
Measures of use of lysergic acid diethylamide (LSD) in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used LSD?" The question about recency of use was asked if respondents previously reported any use of LSD in their lifetime.
SEE: "Current Use," "Ecstasy Use," "Hallucinogen Use," "Lifetime Use," "Past Month Use," "Past Year Use," "PCP Use," "Prevalence," and "Recency of Use."
Marijuana Use
Measures of use of marijuana in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used marijuana or hashish?" The question about recency of use was asked if respondents previously reported any use of marijuana or hashish in their lifetime. Responses to noncore questions about use of cigars with marijuana in them (blunts) were not included in these measures. Creation of these measures did not take into account responses to noncore questions that have been included in the survey since 2013 about use of marijuana in the past 12 months that was recommended by a doctor or other health care professional.
The following definitional information preceded the question about lifetime use of marijuana: "The next questions are about marijuana and hashish. Marijuana is also called pot or grass. Marijuana is usually smoked, either in cigarettes called joints, or in a pipe. It is sometimes cooked in food. Hashish is a form of marijuana that is also called hash. It is usually smoked in a pipe. Another form of hashish is hash oil."
SEE: "Blunts," "Core," "Current Use," "Illicit Drugs," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," "Prior Year Marijuana Use," and "Recency of Use."
Medicaid
Medicaid is a public assistance program that pays for medical care for low-income and disabled persons. Respondents were asked specifically about the Medicaid program in the State where they lived. Respondents aged 12 to 19 were asked specifically about the State Children's Health Insurance Program (SCHIP) in their State. Respondents aged 12 to 19 who reported that they were covered by the SCHIP in their State also were classified as being covered by Medicaid. Respondents aged 65 or older who reported that they were covered by Medicaid were asked to verify that their answer was correct.
NOTE: For youths aged 12 to 17 and those respondents who were unable to respond to the health insurance or income questions, proxy responses were accepted from a household member identified as being better able to give the correct information about health insurance and income.
SEE: "Medicare."
Medicare
Medicare is a health insurance program for persons aged 65 or older and for certain disabled persons. Respondents under the age of 65 who reported that they were covered by Medicare were asked to verify that their answer was correct.
NOTE: For youths aged 12 to 17 and those respondents who were unable to respond to the health insurance or income questions, proxy responses were accepted from a household member identified as being better able to give the correct information about health insurance and income.
SEE: "Medicaid."
Methamphetamine Use
Measures of use of methamphetamine (also known as crank, crystal, ice, or speed), Desoxyn®, or Methedrine® in the respondent's lifetime, the past year, and the past month were derived from responses to the core question about recency of use: "How long has it been since you last used methamphetamine, Desoxyn, or Methedrine?" The core question about recency of use was asked if respondents previously reported any use of methamphetamine, Desoxyn®, or Methedrine® in their lifetime that was not prescribed or that they took only for the experience or feeling it caused.
Estimates for methamphetamine use, stimulant use, and nonmedical use of psychotherapeutics from 2006 onward also include responses based on the noncore methamphetamine use items that were added in 2005 and 2006. Estimates for 2002 through 2005 have been adjusted to make them comparable with estimates from 2006 onward that include responses to the noncore methamphetamine items. Unlike the core question about lifetime use, which asks about use of methamphetamine that was not prescribed or was taken only for the experience or feeling it caused, the noncore question asked about any lifetime use of methamphetamine.
SEE: "Core," "Current Use," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," "Source of Psychotherapeutic Drugs," and "Stimulant Use."
Midwest Region
The States included are those in the East North Central Division—Illinois, Indiana, Michigan, Ohio, and Wisconsin; and the West North Central Division—Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, and South Dakota.
SEE: "Geographic Division" and "Region."
Native Hawaiian or Other Pacific Islander
Native Hawaiian, Guamanian or Chamorro, Samoan, or Other Pacific Islander, not of Hispanic, Latino, or Spanish origin. This does not include respondents reporting two or more races. Respondents reporting that they were Native Hawaiian, Guamanian or Chamorro, Samoan, or Other Pacific Islander and of Hispanic, Latino, or Spanish origin were classified as Hispanic. The categories "Guamanian or Chamorro" and "Samoan" have been included in the NSDUH questionnaire since 2013.
SEE: "Hispanic," "Race/Ethnicity," and "Two or More Races."
Need for Alcohol Use Treatment
Respondents were classified as needing treatment for an alcohol use problem if they met at least one of three criteria during the past year: (1) dependence on alcohol; (2) abuse of alcohol; or (3) received treatment for alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center).
SEE: "Abuse," "Dependence," "Prevalence," "Specialty Substance Use Treatment Facility," and "Treatment for a Substance Use Problem."
Need for Illicit Drug or Alcohol Use Treatment
Respondents were classified as needing treatment for an illicit drug or alcohol use problem if they met at least one of three criteria during the past year: (1) dependence on illicit drugs or alcohol; (2) abuse of illicit drugs or alcohol; or (3) received treatment for illicit drug or alcohol use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center).
SEE: "Abuse," "Dependence," "Prevalence," "Specialty Substance Use Treatment Facility," and "Treatment for a Substance Use Problem."
Need for Illicit Drug Use Treatment
Respondents were classified as needing treatment for an illicit drug use problem if they met at least one of three criteria during the past year: (1) dependence on illicit drugs; (2) abuse of illicit drugs; or (3) received treatment for illicit drug use at a specialty facility (i.e., drug and alcohol rehabilitation facility [inpatient or outpatient], hospital [inpatient only], or mental health center).
SEE: "Abuse," "Dependence," "Prevalence," "Specialty Substance Use Treatment Facility," and "Treatment for a Substance Use Problem."
Nicotine (Cigarette) Dependence
A respondent was defined as having nicotine (cigarette) dependence if he or she met either the dependence criteria derived from the Nicotine Dependence Syndrome Scale (NDSS) or the Fagerstrom Test of Nicotine Dependence (FTND).
SEE: "Cigarette Use," "Dependence," and "Prevalence."
Noncore
The NSDUH interview includes two types of sections or modules: (a) core and (b) noncore. A core set of questions that are critical for basic trend measurement of prevalence estimates remains in the survey every year and is contained in the first part of the interview. Noncore questions are supplemental topics included in the latter part of the interview after all the core modules. Noncore topics can be revised, dropped, or added from year to year. These include (but are not limited to) injection drug use, perceived risks of substance use, substance dependence or abuse, arrests, treatment for substance use problems, pregnancy and health care issues, and mental health issues. Noncore demographic questions, which are interviewer-administered using computer-assisted personal interviewing (CAPI) and follow the audio computer-assisted self-interviewing (ACASI) questions, address such topics as immigration, current school enrollment, employment and workplace issues, health insurance coverage, and income. In practice, however, some of the noncore portions of the interview have remained in the survey, relatively unchanged, from year to year (e.g., current health insurance coverage, employment).
SEE: "ACASI," "CAPI," and "Core."
Nonmedical Use of Psychotherapeutics
A core section of the interview contains questions about nonmedical use of four classes of prescription-type psychotherapeutics: pain relievers, tranquilizers, stimulants, and sedatives. Nonmedical use is defined as (1) use of at least one of these medications without a prescription belonging to the respondent or (2) use that occurred simply for the experience or feeling the drug caused.
Estimates for the measures of nonmedical use of psychotherapeutics from 2006 onward also include responses based on the noncore methamphetamine use items that were added in 2005 and 2006. Estimates for 2002 through 2005 have been adjusted to make them comparable with estimates from 2006 onward that include responses to the noncore methamphetamine items. Responses to questions about the nonmedical use of Adderall® (a stimulant) and Ambien® (a sedative), which were added to the survey in 2006, were not included in these measures to maintain the comparability of estimates over time.
Measures of use of nonmedical psychotherapeutic agents in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used any prescription [pain reliever, tranquilizer, stimulant, or sedative] that was not prescribed for you or that you took only for the experience or feeling it caused?"
Questions about nonmedical use of psychotherapeutic drugs were preceded by the following introduction: "Now we have some questions about drugs that people are supposed to take only if they have a prescription from a doctor. We are only interested in your use of a drug if the drug was not prescribed for you, or if you took the drug only for the experience or feeling it caused."
NOTE: The pill card contains pictures and names of specific drugs within each psychotherapeutic category. For example, pictures and the names of Valium®, Librium®, and other tranquilizers are shown when the section on tranquilizers is introduced.
SEE: "Core," "Current Use," "Lifetime Use," "Methamphetamine Use," "Noncore," "Pain Reliever Use," "Past Month Use," "Past Year Use," "Pill Cards," "Prevalence," "Psychotherapeutic Drugs," "Recency of Use," "Sedative Use," "Source of Psychotherapeutic Drugs," "Stimulant Use," and "Tranquilizer Use."
Nonmetro
SEE: "County Type."
Nonprescription Cough or Cold Medicine Use
Measures of nonmedical use of nonprescription cough or cold medicine in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "Earlier, the computer recorded that you have taken a non-prescription cough or cold medicine just to get high. How long has it been since you last took one of these cough or cold medicines to get high?" The questions about nonprescription cough or cold medicine use were added to a noncore section of the interview in 2006 and were not incorporated in estimates of use of illicit drugs or illicit drugs other than marijuana because inclusion of these questions would affect the comparability of estimates over time.
SEE: "Core," "Current Use," "Illicit Drugs," "Illicit Drugs Other Than Marijuana," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Northeast Region
The States included are those in the New England Division—Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont; and the Middle Atlantic Division—New Jersey, New York, and Pennsylvania.
SEE: "Geographic Division" and "Region."
OxyContin® Use
Measures of nonmedical use of the prescription pain reliever OxyContin® in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used OxyContin that was not prescribed for you or that you took only for the experience or feeling it caused?" The question about recency of use was asked if respondents previously reported any nonmedical use of OxyContin® in their lifetime.
SEE: "Current Use," "Lifetime Use," "Pain Reliever Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Pain Reliever Use
Measures of the nonmedical use of prescription-type pain relievers in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used any prescription pain reliever that was not prescribed for you, or that you took only for the experience or feeling it caused?" The question about recency of use was asked if respondents previously reported any nonmedical use of prescription pain relievers in their lifetime.
Respondents were asked a series of gate questions about any nonmedical use of specific prescription pain relievers in their lifetime. These gate questions were preceded by the following definitional information about pain relievers: "These questions are about the use of pain relievers. We are not interested in your use of over-the-counter pain relievers such as aspirin, Tylenol, or Advil that can be bought in drug stores or grocery stores without a doctor's prescription. Card A shows pictures of some different types of prescription pain relievers and lists the names of some others. These pictures show only pills, but we are interested in your use of any form of prescription pain relievers that were not prescribed for you or that you took only for the experience or feeling they caused."
Gate questions asked whether respondents ever, even once, used the following prescription pain relievers that were not prescribed for respondents or that they took only for the experience or feeling they caused; unless indicated otherwise, pictures of these pain relievers were shown on Pill Card A to aid respondents in identifying pain relievers they used nonmedically: (a) Darvocet®, Darvon®, or Tylenol® with Codeine; (b) Percocet®, Percodan®, or Tylox®; (c) Vicodin®, Lortab®, or Lorcet®; (d) Codeine; (e) Demerol®; (f) Dilaudid®; (g) Fioricet®; (h) Fiorinal®; (i) Hydrocodone; (j) Methadone; (k) Morphine; (l) OxyContin®; (m) Phenaphen® with Codeine; (n) Propoxyphene; (o) SK-65®; (p) Stadol® (not pictured); (q) Talacen®; (r) Talwin®; (s) Talwin® NX; (t) Tramadol (not pictured); (u) Ultram®; and (v) any other prescription pain reliever besides the ones shown on Card A.
SEE: "Core," "Current Use," "Lifetime Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "OxyContin® Use," "Past Month Use," "Past Year Use," "Pill Cards," "Prevalence," "Psychotherapeutic Drugs," "Recency of Use," "Sedative Use," "Source of Psychotherapeutic Drugs," "Stimulant Use," and "Tranquilizer Use."
Past Month Daily Cigarette Use
A respondent was defined as being a past month daily cigarette user if he or she smoked part or all of a cigarette on each of the past 30 days. Respondents were asked about the number of days they smoked a cigarette in this period if they previously reported that they smoked part or all of a cigarette in the past 30 days.
SEE: "Cigarette Use."
Past Month Use
This measure indicates use of a specific substance in the 30 days prior to the interview. Respondents who indicated past month use of a specific substance also were classified as lifetime and past year users.
SEE: "Current Use," "Lifetime Use," "Past Year Use," "Prevalence," and "Recency of Use."
Past Year Incidence
SEE: "Incidence."
Past Year Use
This measure indicates use of a specific substance in the 12 months prior to the interview. This definition includes those respondents who last used the substance in the 30 days prior to the interview. Respondents who indicated past year use of a specific substance also were classified as lifetime users.
SEE: "Current Use," "Lifetime Use," "Past Month Use," "Prevalence," and "Recency of Use."
PCP Use
Measures of use of phencyclidine (PCP) in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used PCP?" The question about recency of use was asked if respondents previously reported any use of PCP in their lifetime.
SEE: "Current Use," "Ecstasy Use," "Hallucinogen Use," "Lifetime Use," "LSD Use," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Perceived Availability
Respondents were asked to assess how difficult or easy it would be for them to get various illicit drugs if they wanted these drugs. Response options were (1) probably impossible, (2) very difficult, (3) fairly difficult, (4) fairly easy, and (5) very easy.
Perceived Need for Alcohol Use Treatment
Respondents were classified as perceiving a need for alcohol use treatment if they reported feeling a need for alcohol use treatment when asked, "During the past 12 months, did you need treatment or counseling for your use of alcohol?" or if they indicated feeling a need for additional treatment specifically for alcohol use when asked, "During the past 12 months, for which of the following drugs did you need additional treatment or counseling?"
SEE: "Prevalence" and "Treatment for a Substance Use Problem."
Perceived Need for Illicit Drug or Alcohol Use Treatment
Respondents were classified as perceiving a need for illicit drug or alcohol use treatment if they were classified as either perceiving a need for illicit drug use treatment or perceiving a need for alcohol use treatment.
SEE: "Perceived Need for Alcohol Use Treatment" and "Perceived Need for Illicit Drug Use Treatment."
Perceived Need for Illicit Drug Use Treatment
Respondents were classified as perceiving a need for illicit drug use treatment if they reported feeling a need for treatment for the use of one or more drugs when asked specifically about each of the individual drugs they had indicated using, "During the past 12 months, did you need treatment or counseling for your use of (drug)?" They also were classified as perceiving a need for illicit drug use treatment if they indicated feeling a need for additional treatment specifically for the use of one or more drugs when asked, "During the past 12 months, for which of the following drugs did you need additional treatment or counseling?" The response list of drugs included marijuana/hashish, cocaine or crack, heroin, hallucinogens, inhalants, prescription pain relievers, prescription tranquilizers, prescription stimulants, prescription sedatives, or some other drug.
SEE: "Prevalence" and "Treatment for a Substance Use Problem."
Perceived Risk/Harmfulness
Respondents were asked to assess the extent to which people risk harming themselves physically and in other ways when they use various illicit drugs, alcohol, and cigarettes, with various levels of frequency. Response options were (1) no risk, (2) slight risk, (3) moderate risk, and (4) great risk.
Percentages
All of the estimates presented in the national findings report8 and the detailed tables contain percentages based on weighted data.
SEE: "Rounding."
Pill Cards
The pill cards contain pictures and names of specific drugs within each psychotherapeutic category to assist respondents with recognition and recall. Respondents are shown the appropriate pill cards at the beginning of each of the questionnaire sections for prescription pain relievers, prescription tranquilizers, prescription stimulants, and prescription sedatives. For example, pictures and the names of Valium®, Librium®, and other prescription tranquilizers are shown when the questionnaire section on tranquilizers is introduced.
SEE: "Current Use," "Lifetime Use," "Nonmedical Use of Psychotherapeutics," "Pain Reliever Use," "Past Month Use," "Past Year Use," "Prevalence," "Psychotherapeutic Drugs," "Recency of Use," "Sedative Use," "Stimulant Use," and "Tranquilizer Use."
Prevalence
Prevalence is a general term used to describe the estimates for lifetime, past year, and past month substance use; dependence or abuse; or other behaviors of interest within a given period (e.g., the past 12 months). Other behaviors of interest include delinquent behavior, driving under the influence of alcohol or drugs, perceived need for alcohol or illicit drug use treatment, and treatment for a substance use problem. Unlike incidence, prevalence measures for substance use include persons who used a given substance in the lifetime, past year, or past month periods regardless of when they first used it.
SEE: "Abuse," "Current Use," "Delinquent Behavior," "Dependence," "Driving Under the Influence," "Incidence," "Need for Illicit Drug or Alcohol Use Treatment," "Nicotine (Cigarette) Dependence," "Perceived Need for Alcohol Use Treatment," "Perceived Need for Illicit Drug or Alcohol Use Treatment," "Perceived Need for Illicit Drug Use Treatment," "Recency of Use," and "Treatment for a Substance Use Problem."
Prior Year Marijuana Use
A respondent was defined as engaging in prior year marijuana use if he or she used marijuana or hashish 12 to 23 months prior to the interview date. Prior year marijuana use is different from past year marijuana use because past year marijuana use indicates use in the past 12 calendar months prior to the interview date, whereas prior year marijuana use is defined as using marijuana in the year prior to the past year (i.e., within 12 to 23 months prior to the interview date).
SEE: "Marijuana Use."
Psychotherapeutic Drugs
Psychotherapeutic drugs are prescription-type medications with legitimate medical uses as pain relievers, tranquilizers, stimulants, and sedatives. The self-administered portion of the interview covers nonmedical use of these drugs, which involves use without a prescription belonging to the respondent or use that occurred simply for the experience or feeling the drug caused. Estimates for psychotherapeutic drug measures from 2006 onward include responses based on the core questions about nonmedical use of psychotherapeutics and the noncore methamphetamine use items that were added in 2005 and 2006. Estimates for 2002 through 2005 have been adjusted to make them comparable with estimates from 2006 onward that include responses to the noncore methamphetamine items.
SEE: "ACASI," "Core," "Current Use," "Lifetime Use," "Methamphetamine Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "Pain Reliever Use," "Past Month Use," "Past Year Use," "Pill Cards," "Prevalence," "Recency of Use," "Sedative Use," "Source of Psychotherapeutic Drugs," "Stimulant Use," and "Tranquilizer Use."
Race/Ethnicity
Race/ethnicity is used to refer to the respondent's self-classification of racial and ethnic origin and identification. For Hispanic origin, respondents were asked, "Are you of Hispanic, Latino, or Spanish origin or descent?" For race, respondents were asked, "Which of these groups describes you?" Response options for race were (1) white, (2) black/African American, (3) American Indian or Alaska Native, (4) Native Hawaiian, (5) Guamanian or Chamorro, (6) Samoan, (7) Other Pacific Islander, (8) Asian, and (9) Other. The categories for Guamanian or Chamorro and for Samoan have been included in the NSDUH questionnaire since 2013.
Respondents were allowed to choose more than one of these groups. Categories for a combined race/ethnicity variable included Hispanic (regardless of race); non-Hispanic groups where respondents indicated only one race (white, black, American Indian or Alaska Native, Native Hawaiian, Guamanian or Chamorro, Samoan, or Other Pacific Islander, Asian); and non-Hispanic groups where respondents reported two or more races. However, respondents choosing more than one category from among Native Hawaiian, Guamanian or Chamorro, Samoan, and Other Pacific Islander but no other categories are classified as being in the "Native Hawaiian or Other Pacific Islander" category instead of the "two or more races" category. These categories are based on classifications developed by the U.S. Census Bureau.
SEE: "American Indian or Alaska Native," "Asian," "Black," "Hispanic," "Native Hawaiian or Other Pacific Islander," "Two or More Races," and "White."
Recency of Use
The recency question for each substance was the source for the lifetime, past year, and past month prevalence estimates. Respondents were asked the relevant recency question if they previously reported any use of the substance in their lifetime.
The question was essentially the same for all classes of substances: "How long has it been since you last used [substance name]?" For the four classes of psychotherapeutics, the phrase "that was not prescribed for you or that you took only for the experience or feeling it caused" was added after the name of the drug.
For tobacco products (cigarettes, snuff, chewing tobacco, or cigars), a question first was asked about use in the past 30 days. If the respondent did not use the product in the past 30 days, the recency question was asked as above, with the response options (1) more than 30 days ago but within the past 12 months; (2) more than 12 months ago but within the past 3 years; and (3) more than 3 years ago. For the remaining substances, the response options were (1) within the past 30 days; (2) more than 30 days ago but within the past 12 months; and (3) more than 12 months ago.
SEE: "Current Use," "Lifetime Use," "Past Month Use," "Past Year Use," and "Prevalence."
Region
Four regions, Northeast, Midwest, South, and West, are based on classifications developed by the U.S. Census Bureau.
The decision rules for the rounding of percentages were as follows.
If the second number to the right of the decimal point was greater than or equal to 5, the first number to the right of the decimal point was rounded up to the next higher number.
If the second number to the right of the decimal point was less than 5, the first number to the right of the decimal point remained the same.
Thus, a prevalence estimate of 16.55 percent would be rounded to 16.6 percent, while an estimate of 16.44 percent would be rounded to 16.4 percent. Although the percentages in the tables generally total 100 percent, the use of rounding sometimes produces a total of slightly less than or more than 100 percent.
SEE: "Percentages."
Salvia divinorum Use
Measures of use of Salvia divinorum in the respondent's lifetime, the past year, and the past month were derived from responses to the noncore question about recency of use: "Earlier, the computer recorded that you have used Salvia divinorum. How long has it been since you last used Salvia divinorum?" The questions about Salvia divinorum were added to a noncore section of the interview in 2006 and were not incorporated in estimates of use of hallucinogens, illicit drugs, or illicit drugs other than marijuana because inclusion of these questions would affect the comparability of estimates over time.
SEE: "Core," "Current Use," "Hallucinogen Use," "Illicit Drugs," "Illicit Drugs Other Than Marijuana," "Lifetime Use," "Noncore," "Past Month Use," "Past Year Use," "Prevalence," and "Recency of Use."
Sedative Use
Measures of the nonmedical use of prescription-type sedatives in the respondent's lifetime, the past year, and the past month were derived from responses to the core question about recency of use: "How long has it been since you last used any prescription sedative that was not prescribed for you, or that you took only for the experience or feeling it caused?" Responses to noncore questions about use of the prescription sedative Ambien®, which were added to the survey in 2006, were not included in these measures. The question about recency of use was asked if respondents previously reported any nonmedical use of prescription sedatives in their lifetime.
Respondents were asked a series of gate questions about any nonmedical use of specific prescription sedatives in their lifetime. These gate questions were preceded by the following definitional information about sedatives: "These next questions ask about the use of sedatives or barbiturates. These drugs are also called downers or sleeping pills. People take these drugs to help them relax or to help them sleep. We are not interested in the use of over-the-counter sedatives such as Sominex, Unisom, Nytol, or Benadryl that can be bought in drug stores or grocery stores without a doctor's prescription. Card D shows pictures of different kinds of prescription sedatives and lists the names of some others. These pictures show only pills, but we are interested in your use of any form of prescription sedatives that were not prescribed for you or that you took only for the experience or feeling they caused."
Gate questions asked whether respondents ever, even once, used the following prescription sedatives that were not prescribed for respondents or that they took only for the experience or feeling they caused; unless indicated otherwise, pictures of these sedatives were shown on Pill Card D to aid respondents in identifying sedatives they used nonmedically: (a) Methaqualone (includes Sopor®, Quaalude®) (not pictured); (b) barbiturates, such as Nembutal®, Pentobarbital (not pictured), Seconal®, Secobarbital (not pictured), or Butalbital (not pictured); (c) Restoril® or Temazepam; (d) Amytal®; (e) Butisol®; (f) Chloral Hydrate (not pictured); (g) Dalmane®; (h) Halcion®; (i) Phenobarbital; (j) Placidyl®; (k) Tuinal®; and (l) any other prescription sedative besides the ones shown on Card D.
SEE: "Core," "Current Use," "Lifetime Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "Pain Reliever Use," "Past Month Use," "Past Year Use," "Pill Cards," "Prevalence," "Psychotherapeutic Drugs," "Recency of Use," "Source of Psychotherapeutic Drugs," "Stimulant Use," and "Tranquilizer Use."
Self-Help Group
Respondents who reported that they received treatment for their use of alcohol or drugs in the past 12 months were asked whether they received treatment in a self-help group, such as Alcoholics Anonymous or Narcotics Anonymous. Self-help groups were not considered specialty substance use treatment facilities. Beginning with the 2006 survey, respondents also were asked whether they attended self-help groups in the past 12 months to receive help for their alcohol or drug use, regardless of whether they previously reported receiving any treatment in the past 12 months.
SEE: "Specialty Substance Use Treatment Facility" and "Treatment for a Substance Use Problem."
Significance
Two types of statistical comparisons are presented in NSDUH reports and tables: (1) between two different time points, and (2) between members of demographic subgroups. When tables show trends over time, statistically significant differences between estimates from two different time points (e.g., 2012 and 2013) may be identified at two levels: 0.05 and 0.01. When reports compare estimates between two points in time or between demographic subgroups, a significance level of 0.05 generally is used to determine whether these estimates were statistically different. If differences do not meet the criteria for statistical significance, the values of these estimates are not considered to be different from one another. Estimates that are noted as "low precision" are not compared with other estimates.
SEE: "Low Precision."
Small Metro
SEE: "County Type."
Smokeless Tobacco Use
Measures of use of smokeless tobacco in the respondent's lifetime, the past year, and the past month were derived from responses to the questions about snuff and chewing tobacco use in the past 30 days and the recency of use (if not in the past 30 days): "Now think about the past 30 days—that is, from [DATEFILL] up to and including today. During the past 30 days, have you used snuff, even once?" "How long has it been since you last used snuff?" "Now think about the past 30 days—that is, from [DATEFILL] up to and including today. During the past 30 days, have you used chewing tobacco, even once?" and "How long has it been since you last used chewing tobacco?" Questions about use of snuff in the past 30 days or the most recent use of snuff (if not in the past 30 days) were asked if respondents previously reported any use of snuff in their lifetime. Similarly, questions about use of chewing tobacco in the past 30 days or the most recent use of chewing tobacco (if not in the past 30 days) were asked if respondents previously reported any use of chewing tobacco in their lifetime.
The following information preceded the question about lifetime use of snuff: "These next questions are about your use of snuff, sometimes called dip." The following information preceded the question about lifetime use of chewing tobacco: "The next questions are only about chewing tobacco."
SEE: "Cigar Use," "Cigarette Use," "Current Use," "Lifetime Use," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," and "Tobacco Product Use."
Social Context of Most Recent Underage Alcohol Use
Respondents aged 12 to 20 who reported drinking at least one alcoholic beverage within the past 30 days were asked if they were alone, with one other person, or with more than one person the last time they drank.
SEE: "Alcohol Use" and "Underage Alcohol Use."
Source of Alcohol for Most Recent Underage Alcohol Use
Respondents aged 12 to 20 who reported drinking at least one alcoholic beverage within the past 30 days were asked questions pertaining to the source of the alcohol for their most recent alcohol use. The sources were (1) purchased it himself or herself; (2) it was purchased by someone else; (3) received it from a parent or guardian; (4) received it from another family member aged 21 or older; (5) received it from an unrelated person aged 21 or older; (6) received it from someone under age 21; (7) took it from own home; (8) took it from someone else's home; or (9) got it some other way.
The questions on the source of last alcohol use are presented in two categories: (a) respondent paid (he or she purchased the alcohol or gave someone else money to purchase the alcohol), and (b) respondent did not pay (he or she received the alcohol for free from someone or took the alcohol from his or her own or someone else's home).
SEE: "Alcohol Use" and "Underage Alcohol Use."
Source of Psychotherapeutic Drugs
There are two measures of the source of psychotherapeutic drugs (prescription pain relievers, prescription tranquilizers, prescription stimulants, methamphetamine, and prescription sedatives) that were used nonmedically: (a) how respondents obtained these drugs the last time they used them nonmedically and (b) how respondents obtained these drugs for any nonmedical use in the past month. For all of these drugs except methamphetamine, response options for the source of the medications were as follows: (a) got a prescription from just one doctor; (b) got prescriptions from more than one doctor; (c) wrote a fake prescription; (d) stole from a doctor's office, clinic, hospital, or pharmacy; (e) got from a friend or relative for free; (f) bought from a friend or relative; (g) took from a friend or relative without asking; (h) bought from a drug dealer or other stranger; (i) bought on the Internet; and (j) got in some other way (includes other sources specified by respondents). Methamphetamine users were presented with options (e) through (j) only. Since 2006, respondents who reported that they obtained these drugs from a friend or relative for free were asked how the friend or relative obtained them, using the same response options (a) through (j) as the respondents' source questions.
If respondents last used a psychotherapeutic drug nonmedically in the past 30 days and reported getting that drug from only one source, the source of the psychotherapeutic drug for the most recent use measure was based on that answer. For respondents who reported getting a psychotherapeutic drug from multiple sources in the past 30 days or who last misused that drug more than 30 days ago but in the past 12 months, the source of the psychotherapeutic drug for the most recent use measure was based on their answer to a question about how they got that drug the last time they used it nonmedically. The source of the psychotherapeutic drug for any use in the past month was based only on the answer to the question about sources in the past 30 days. This same definition was applied to the questions that asked how the friend or relative obtained the medications.
Measures of the source of methamphetamine differ from all other measures regarding the source of psychotherapeutic drugs in that they include respondents who reported methamphetamine use in the stimulants module and respondents who reported methamphetamine use in the special drugs module who did not initially report methamphetamine use in the stimulants module because they did not consider it to be a prescription drug. All other measures of the source of psychotherapeutic drugs only include respondents who reported psychotherapeutic drug use in their respective core drug modules.
Respondents were asked the following question(s) if they reported nonmedical use of psychotherapeutic drugs in the past 30 days: "Earlier, the computer recorded that, during the past 30 days, you used [prescription pain relievers, prescription tranquilizers, prescription stimulants, methamphetamine, prescription sedatives] that were not prescribed for you or that you took only for the experience or feeling it caused. How did you get these [fill in relevant drug name from above]? Please enter all of the ways that you got the [fill in relevant drug name from above] you used in the past 30 days."
Respondents were asked the following question(s) if they reported nonmedical use of psychotherapeutic drugs more than 30 days ago but within the past 12 months or if they obtained psychotherapeutic drugs from more than one source in the past 30 days: "Now think about the last time you used [a prescription pain reliever, a prescription tranquilizer, a prescription stimulant, methamphetamine, a prescription sedative] that was not prescribed for you or that you took only for the experience or feeling it caused. How did you get this [fill in relevant drug name from above]?"
SEE: "Core," "Methamphetamine Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "Pain Reliever Use," "Psychotherapeutic Drugs," "Sedative Use," "Stimulant Use," and "Tranquilizer Use."
South Region
The States included are those in the South Atlantic Division—Delaware, District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, and West Virginia; the East South Central Division—Alabama, Kentucky, Mississippi, and Tennessee; and the West South Central Division—Arkansas, Louisiana, Oklahoma, and Texas.
SEE: "Geographic Division" and "Region."
Specialty Substance Use Treatment Facility
This was defined as a drug or alcohol rehabilitation facility (inpatient or outpatient), a hospital (inpatient only), or a mental health center.
SEE: "Need for Illicit Drug or Alcohol Use Treatment," "Self-Help Group," and "Treatment for a Substance Use Problem."
Stimulant Use
Measures of nonmedical use of prescription-type stimulants in the respondent's lifetime, the past year, and the past month were derived from responses to the core questions about recency of use: "How long has it been since you last used any prescription stimulant that was not prescribed for you or that you took only for the experience or feeling it caused?" and "How long has it been since you last used Methamphetamine, Desoxyn, or Methedrine?" Questions about recency of use were asked if respondents previously reported any nonmedical use of prescription stimulants or methamphetamine in their lifetime.
Estimates for the stimulant use measures from 2006 onward included responses based on the noncore methamphetamine use items that were added in 2005 and 2006. Estimates for 2002 through 2005 have been adjusted to make them comparable with estimates from 2006 onward that include responses to the noncore methamphetamine items. However, measures of stimulant use do not include data from noncore questions added to the survey in 2006 about the use of the prescription stimulant Adderall®.
Respondents were asked a series of gate questions about any nonmedical use of specific prescription stimulants in their lifetime. These gate questions were preceded by the following definitional information about stimulants: "These next questions ask about the use of drugs such as amphetamines that are known as stimulants, uppers, or speed. People sometimes take these drugs to lose weight, to stay awake, or for attention deficit disorders. We are not interested in the use of over-the-counter stimulants such as Dexatrim or No-Doz that can be bought in drug stores or grocery stores without a doctor's prescription. Card C shows pictures of some different kinds of prescription stimulants and lists the names of some others. These pictures show only pills, but we are interested in your use of any form of prescription stimulants that were not prescribed for you or that you took only for the experience or feeling they caused."
Gate questions asked whether respondents ever, even once, used the following prescription stimulants that were not prescribed for respondents or that they took only for the experience or feeling they caused; unless indicated otherwise, pictures of these stimulants were shown on Pill Card C to aid respondents in identifying stimulants they used nonmedically: (a) Methamphetamine (crank, crystal, ice, or speed) (not pictured), Desoxyn®, or Methedrine® (not pictured); (b) prescription diet pills, such as Amphetamines (not pictured), Benzedrine®, Biphetamine®, Fastin®, or Phentermine; (c) Ritalin® or Methylphenidate; (d) Cylert®; (e) Dexedrine®; (f) Dextroamphetamine; (g) Didrex®; (h) Eskatrol®; (i) Ionamin®; (j) Mazanor®; (k) Obedrin-LA® (not pictured); (l) Plegine®; (m) Preludin®; (n) Sanorex®; (o) Tenuate®; and (p) any other prescription stimulant besides the ones shown on Card C.
SEE: "Core," "Current Use," "Lifetime Use," "Methamphetamine Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "Pain Reliever Use," "Past Month Use," "Past Year Use," "Pill Cards," "Prevalence," "Psychotherapeutic Drugs," "Recency of Use," "Sedative Use," "Source of Psychotherapeutic Drugs," and "Tranquilizer Use."
Substance Use Disorder
Substance use disorder is defined as meeting criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)9 for dependence or abuse for illicit drugs or alcohol.
SEE: "Abuse" and "Dependence."
Substance Use Treatment
SEE: "Treatment for a Substance Use Problem."
Tobacco Product Use
This measure indicates use of any tobacco product: cigarettes, chewing tobacco, snuff, cigars, and pipe tobacco. Tobacco product use in the past year includes past month pipe tobacco use. Tobacco product use in the past year does not include use of pipe tobacco more than 30 days ago but within 12 months of the interview because the survey did not capture this information. Measures of tobacco product use in the respondent's lifetime, the past year, or the past month also do not include reports from noncore questions about use of cigars with marijuana in them (blunts).
Measures of the nonmedical use of prescription-type tranquilizers in the respondent's lifetime, the past year, and the past month were derived from responses to the question about recency of use: "How long has it been since you last used any prescription tranquilizer that was not prescribed for you, or that you took only for the experience or feeling it caused?" The question about recency of use was asked if respondents previously reported any nonmedical use of prescription tranquilizers in their lifetime.
Respondents were asked a series of gate questions about any nonmedical use of specific prescription tranquilizers in their lifetime. These gate questions were preceded by the following definitional information about tranquilizers: "These next questions ask about the use of tranquilizers. Tranquilizers are usually prescribed to relax people, to calm people down, to relieve anxiety, or to relax muscle spasms. Some people call tranquilizers nerve pills. Card B shows pictures of some different kinds of prescription tranquilizers. These pictures show only pills, but we are interested in your use of any form of prescription tranquilizers that were not prescribed for you, or that you took only for the experience or feeling they caused."
Gate questions asked whether respondents ever, even once, used the following prescription tranquilizers that were not prescribed for respondents or that they took only for the experience or feeling they caused; unless indicated otherwise, pictures of these tranquilizers were shown on Pill Card B to aid respondents in identifying tranquilizers they used nonmedically: (a) Klonopin® or Clonazepam; (b) Xanax®, Alprazolam, Ativan®, or Lorazepam; (c) Valium® or Diazepam; (d) Atarax®; (e) BuSpar®; (f) Equanil®; (g) Flexeril®; (h) Librium®; (i) Limbitrol®; (j) Meprobamate; (k) Miltown®; (l) Rohypnol®; (m) Serax®; (n) Soma®; (o) Tranxene®; (p) Vistaril®; and (q) any other prescription tranquilizer besides the ones shown on Card B.
SEE: "Core," "Current Use," "Lifetime Use," "Noncore," "Nonmedical Use of Psychotherapeutics," "Pain Reliever Use," "Past Month Use," "Past Year Use," "Pill Cards," "Prevalence," "Psychotherapeutic Drugs," "Recency of Use," "Sedative Use," "Source of Psychotherapeutic Drugs," and "Stimulant Use."
Treatment for a Substance Use Problem
Respondents were defined as having received treatment for a substance use problem if they reported receiving treatment for illicit drug use, alcohol use, or both illicit drug and alcohol use in the past 12 months in any of the following locations: a hospital overnight as an inpatient, a residential drug or alcohol rehabilitation facility where they stayed overnight, a drug or alcohol rehabilitation facility as an outpatient, a mental health facility as an outpatient, an emergency room, a private doctor's office, a prison or jail, a self-help group, or some other place. Emergency rooms, private doctors' offices, prisons or jails, and self-help groups were not considered specialty substance use treatment facilities. Reports of treatment in some other place were considered to be treatment in specialty substance use treatment facilities only if respondents specified a location that corresponded to drug or alcohol rehabilitation facilities (inpatient or outpatient), hospitals (inpatient only), or mental health centers.
SEE: "Alcohol Use," "Illicit Drugs," "Need for Illicit Drug or Alcohol Use Treatment," "Prevalence," "Self-Help Group," and "Specialty Substance Use Treatment Facility."
Two or More Races
Respondents were asked to report which racial group describes them. Response options were (1) white, (2) black or African American, (3) American Indian or Alaska Native, (4) Native Hawaiian, (5) Guamanian or Chamorro, (6) Samoan, (7) Other Pacific Islander, (8) Asian, and (9) Other. The categories for Guamanian or Chamorro and for Samoan have been included in the NSDUH questionnaire since 2013.
Respondents were allowed to choose more than one of these groups. Persons who chose more than one category from among Native Hawaiian, Guamanian or Chamorro, Samoan, and Other Pacific Islander (and no additional categories) were classified in a single category: Native Hawaiian or Other Pacific Islander. Otherwise, persons reporting two or more of the above groups and that they were not of Hispanic, Latino, or Spanish origin were included in a "Two or More Races" category. Persons reporting two or more races do not include respondents who reported more than one Asian subgroup but who reported "Asian" as their only race. Respondents reporting two or more races and reporting that they were of Hispanic, Latino, or Spanish origin were classified as Hispanic.
SEE: "Hispanic" and "Race/Ethnicity."
Underage Alcohol Use
Underage alcohol use was defined as any use of alcohol by persons aged 12 to 20 in the respondent's lifetime, past year, or past month.
SEE: "Alcohol Use," "Binge Use of Alcohol," "Current Use," "Heavy Use of Alcohol," "Lifetime Use," "Location of Most Recent Underage Alcohol Use," "Past Month Use," "Past Year Use," "Prevalence," "Recency of Use," "Social Context of Most Recent Underage Alcohol Use," and "Source of Alcohol for Most Recent Underage Alcohol Use."
West Region
The States included are those in the Mountain Division—Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, and Wyoming; and the Pacific Division—Alaska, California, Hawaii, Oregon, and Washington.
SEE: "Geographic Division" and "Region."
White
White, not of Hispanic, Latino, or Spanish origin. This does not include respondents reporting two or more races. Respondents reporting that they were white and of Hispanic, Latino, or Spanish origin were classified as Hispanic.
SEE: "Hispanic," "Race/Ethnicity," and "Two or More Races."
Illicit Drug Use Tables - 1.1 to 1.92 (Numbers in Thousands and Percentages)
Table 1.1A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
124,808
127,458
41,479
41,591
23,863
24,573
Marijuana and Hashish
111,239a
114,712
31,513
32,952
18,855
19,810
Cocaine
37,688
37,634
4,671
4,182
1,650
1,549
Crack
9,015
8,870
921a
632
443
377
Heroin
4,565
4,812
669
681
335
289
Hallucinogens
37,908
39,736
4,306
4,430
1,134
1,333
LSD
23,735
24,770
1,057
1,111
184
229
PCP
6,552
6,462
172a
90
32
33
Ecstasy
16,162b
17,815
2,610
2,588
628
660
Inhalants
21,095
21,068
1,693
1,533
493
496
Nonmedical Use of Psychotherapeutics2,3
54,389
53,172
16,666a
15,348
6,831
6,484
Pain Relievers
37,045
35,473
12,489b
11,082
4,862
4,521
OxyContin®
6,579
6,973
1,477
1,442
358
492
Tranquilizers
23,639
23,493
6,073a
5,269
2,139a
1,705
Stimulants3
21,498
21,656
3,317
3,492
1,171
1,365
Methamphetamine3
12,259
12,257
1,155
1,186
440
595
Sedatives
7,939
7,480
590
639
270
251
ILLICIT DRUGS OTHER THAN MARIJUANA1
78,034
78,076
21,267a
19,868
8,883
8,665
140320
Table 1.1B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
48.0
48.6
16.0
15.9
9.2
9.4
Marijuana and Hashish
42.8
43.7
12.1
12.6
7.3
7.5
Cocaine
14.5
14.3
1.8
1.6
0.6
0.6
Crack
3.5
3.4
0.4a
0.2
0.2
0.1
Heroin
1.8
1.8
0.3
0.3
0.1
0.1
Hallucinogens
14.6
15.1
1.7
1.7
0.4
0.5
LSD
9.1
9.4
0.4
0.4
0.1
0.1
PCP
2.5
2.5
0.1a
0.0
0.0
0.0
Ecstasy
6.2a
6.8
1.0
1.0
0.2
0.3
Inhalants
8.1
8.0
0.7
0.6
0.2
0.2
Nonmedical Use of Psychotherapeutics2,3
20.9
20.3
6.4a
5.8
2.6
2.5
Pain Relievers
14.2a
13.5
4.8b
4.2
1.9
1.7
OxyContin®
2.5
2.7
0.6
0.5
0.1
0.2
Tranquilizers
9.1
9.0
2.3a
2.0
0.8a
0.6
Stimulants3
8.3
8.3
1.3
1.3
0.5
0.5
Methamphetamine3
4.7
4.7
0.4
0.5
0.2
0.2
Sedatives
3.1
2.9
0.2
0.2
0.1
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
30.0
29.8
8.2a
7.6
3.4
3.3
140320
Table 1.2A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
845
772
559a
466
283a
207
Marijuana and Hashish
261
240
209
197
93
81
Cocaine
11
9
10
8
1
2
Crack
1
2
*
2
*
2
Heroin
2
6
2
5
*
1
Hallucinogens
49
58
33
35
19
11
LSD
10
15
4
9
2
5
PCP
5
6
3
2
2
1
Ecstasy
14
19
8
18
4
1
Inhalants
394
336
177
145
74
47
Nonmedical Use of Psychotherapeutics2,3
383
330
269b
187
136
100
Pain Relievers
332
267
232b
150
118a
75
OxyContin®
15
22
11
13
7
6
Tranquilizers
45
47
23
31
7
16
Stimulants3
34
49
18
25
6
14
Methamphetamine3
11
12
5
7
2
4
Sedatives
33
28
13
18
9
12
ILLICIT DRUGS OTHER THAN MARIJUANA1
688
612
420a
322
212a
143
140320
Table 1.2B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or 13: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
10.5
9.7
6.9
5.8
3.5a
2.6
Marijuana and Hashish
3.2
3.0
2.6
2.5
1.2
1.0
Cocaine
0.1
0.1
0.1
0.1
0.0
0.0
Crack
0.0
0.0
*
0.0
*
0.0
Heroin
0.0
0.1
0.0
0.1
*
0.0
Hallucinogens
0.6
0.7
0.4
0.4
0.2
0.1
LSD
0.1
0.2
0.0
0.1
0.0
0.1
PCP
0.1
0.1
0.0
0.0
0.0
0.0
Ecstasy
0.2
0.2
0.1
0.2
0.1
0.0
Inhalants
4.9
4.2
2.2
1.8
0.9
0.6
Nonmedical Use of Psychotherapeutics2,3
4.8
4.1
3.3b
2.3
1.7
1.3
Pain Relievers
4.1
3.3
2.9b
1.9
1.5a
0.9
OxyContin®
0.2
0.3
0.1
0.2
0.1
0.1
Tranquilizers
0.6
0.6
0.3
0.4
0.1
0.2
Stimulants3
0.4
0.6
0.2
0.3
0.1
0.2
Methamphetamine3
0.1
0.1
0.1
0.1
0.0
0.1
Sedatives
0.4
0.4
0.2
0.2
0.1
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
8.5
7.7
5.2a
4.0
2.6a
1.8
140320
Table 1.3A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
1,936
1,862
1,368
1,343
684
664
Marijuana and Hashish
1,225
1,210
968
975
515
492
Cocaine
58
37
33
25
9
12
Crack
10
5
4
2
*
*
Heroin
26a
10
17
9
*
5
Hallucinogens
216a
151
149a
99
42
37
LSD
61
45
37
30
9
6
PCP
47b
17
26
10
2
4
Ecstasy
111a
71
66a
39
20
10
Inhalants
640
552
250
197
56
50
Nonmedical Use of Psychotherapeutics2,3
773
694
500
477
213
184
Pain Relievers
629
590
409
402
181
158
OxyContin®
87
68
49
48
17
9
Tranquilizers
203
165
130
95
33
30
Stimulants3
146
123
100
77
34
18
Methamphetamine3
45a
25
26
13
15b
2
Sedatives
65
48
29
22
12
10
ILLICIT DRUGS OTHER THAN MARIJUANA1
1,233
1,104
732
649
271
244
140320
Table 1.3B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 14 or 15: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
23.1
21.9
16.3
15.8
8.2
7.8
Marijuana and Hashish
14.6
14.2
11.5
11.4
6.1
5.8
Cocaine
0.7
0.4
0.4
0.3
0.1
0.1
Crack
0.1
0.1
0.1
0.0
*
*
Heroin
0.3a
0.1
0.2
0.1
*
0.1
Hallucinogens
2.6b
1.8
1.8b
1.2
0.5
0.4
LSD
0.7
0.5
0.4
0.3
0.1
0.1
PCP
0.6b
0.2
0.3
0.1
0.0
0.0
Ecstasy
1.3a
0.8
0.8a
0.5
0.2
0.1
Inhalants
7.6
6.5
3.0a
2.3
0.7
0.6
Nonmedical Use of Psychotherapeutics2,3
9.2
8.1
6.0
5.6
2.5
2.2
Pain Relievers
7.5
6.9
4.9
4.7
2.2
1.8
OxyContin®
1.0
0.8
0.6
0.6
0.2
0.1
Tranquilizers
2.4
1.9
1.6
1.1
0.4
0.3
Stimulants3
1.7
1.4
1.2
0.9
0.4a
0.2
Methamphetamine3
0.5a
0.3
0.3
0.2
0.2b
0.0
Sedatives
0.8
0.6
0.3
0.3
0.1
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
14.7a
13.0
8.7
7.6
3.2
2.9
140320
Table 1.4A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
3,263
3,160
2,542
2,477
1,409
1,326
Marijuana and Hashish
2,745
2,643
2,187
2,174
1,192
1,189
Cocaine
196
170
137
98
20
30
Crack
24
15
14
7
1
1
Heroin
32
23
12
17
*
6
Hallucinogens
559
493
372
348
99
106
LSD
178
160
112
111
15a
40
PCP
43
23
19
17
1
2
Ecstasy
364a
280
214
176
49
37
Inhalants
579b
439
220b
139
58b
24
Nonmedical Use of Psychotherapeutics2,3
1,325a
1,165
873
778
343a
264
Pain Relievers
1,108a
949
691
605
259a
193
OxyContin®
220
184
127a
89
25
14
Tranquilizers
455a
360
299a
221
100b
45
Stimulants3
315
265
207
172
77
52
Methamphetamine3
89
82
51
53
14
16
Sedatives
77a
49
39
24
5
3
ILLICIT DRUGS OTHER THAN MARIJUANA1
1,770a
1,563
1,145a
1,008
436
370
140320
Table 1.4B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 16 or 17: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
38.5
37.6
30.0
29.5
16.6
15.8
Marijuana and Hashish
32.4
31.5
25.8
25.9
14.0
14.2
Cocaine
2.3
2.0
1.6
1.2
0.2
0.4
Crack
0.3
0.2
0.2
0.1
0.0
0.0
Heroin
0.4
0.3
0.1
0.2
*
0.1
Hallucinogens
6.6
5.9
4.4
4.1
1.2
1.3
LSD
2.1
1.9
1.3
1.3
0.2a
0.5
PCP
0.5
0.3
0.2
0.2
0.0
0.0
Ecstasy
4.3a
3.3
2.5
2.1
0.6
0.4
Inhalants
6.8b
5.2
2.6b
1.7
0.7b
0.3
Nonmedical Use of Psychotherapeutics2,3
15.6a
13.9
10.3
9.3
4.0a
3.1
Pain Relievers
13.1a
11.3
8.2
7.2
3.1a
2.3
OxyContin®
2.6
2.2
1.5a
1.1
0.3
0.2
Tranquilizers
5.4a
4.3
3.5a
2.6
1.2b
0.5
Stimulants3
3.7
3.1
2.4
2.0
0.9
0.6
Methamphetamine3
1.0
1.0
0.6
0.6
0.2
0.2
Sedatives
0.9a
0.6
0.5
0.3
0.1
0.0
ILLICIT DRUGS OTHER THAN MARIJUANA1
20.9b
18.6
13.5a
12.0
5.1
4.4
140320
Table 1.5A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
7,055
6,819
5,258
5,061
3,174
2,978
Marijuana and Hashish
6,304
6,135
4,684
4,524
2,847
2,684
Cocaine
1,082a
875
594a
450
140
125
Crack
154a
96
65b
24
14
4
Heroin
161
126
89
53
47
23
Hallucinogens
1,858
1,736
1,090
927
320
281
LSD
647
606
322
301
58
70
PCP
113
77
40a
15
8
2
Ecstasy
1,376
1,220
689a
532
192a
112
Inhalants
996
866
239
218
60
51
Nonmedical Use of Psychotherapeutics2,3
3,240a
2,892
1,892b
1,602
694
584
Pain Relievers
2,622a
2,302
1,437b
1,179
509a
389
OxyContin®
581
540
212
150
41
44
Tranquilizers
1,359
1,224
679a
545
174
143
Stimulants3
964
890
522
460
142
152
Methamphetamine3
313a
220
151
110
32
35
Sedatives
136
168
56
60
17
16
ILLICIT DRUGS OTHER THAN MARIJUANA1
4,034
3,700
2,506a
2,207
982
879
140320
Table 1.5B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 20: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
53.2
51.7
39.6
38.4
23.9
22.6
Marijuana and Hashish
47.5
46.5
35.3
34.3
21.4
20.3
Cocaine
8.1a
6.6
4.5a
3.4
1.1
0.9
Crack
1.2a
0.7
0.5b
0.2
0.1
0.0
Heroin
1.2
1.0
0.7
0.4
0.4
0.2
Hallucinogens
14.0
13.2
8.2
7.0
2.4
2.1
LSD
4.9
4.6
2.4
2.3
0.4
0.5
PCP
0.9
0.6
0.3a
0.1
0.1
0.0
Ecstasy
10.4
9.2
5.2a
4.0
1.4a
0.8
Inhalants
7.5
6.6
1.8
1.6
0.4
0.4
Nonmedical Use of Psychotherapeutics2,3
24.4b
21.9
14.3b
12.1
5.2
4.4
Pain Relievers
19.8b
17.4
10.8b
8.9
3.8a
3.0
OxyContin®
4.4
4.1
1.6
1.1
0.3
0.3
Tranquilizers
10.2
9.3
5.1a
4.1
1.3
1.1
Stimulants3
7.3
6.7
3.9
3.5
1.1
1.1
Methamphetamine3
2.4a
1.7
1.1
0.8
0.2
0.3
Sedatives
1.0
1.3
0.4
0.5
0.1
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
30.4a
28.0
18.9b
16.7
7.4
6.7
140320
Table 1.6A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
12,922
13,008
7,292
7,388
4,207
4,513
Marijuana and Hashish
11,748
11,915
6,204
6,476
3,638
3,952
Cocaine
3,186
3,166
1,006
1,093
257
273
Crack
500
467
76
71
23
32
Heroin
503
493
183
191
92
69
Hallucinogens
4,244
4,386
1,147b
1,411
280
336
LSD
1,409a
1,639
300a
407
60
35
PCP
231
250
17
11
4
2
Ecstasy
3,076
3,216
723
847
169
207
Inhalants
1,923
1,746
233
260
63
55
Nonmedical Use of Psychotherapeutics2,3
6,470
6,347
2,837
2,643
1,139
1,077
Pain Relievers
5,137
4,949
2,070
1,881
802
743
OxyContin®
1,430
1,349
356
323
104
63
Tranquilizers
3,061
2,961
1,039
1,023
364
291
Stimulants3
2,410
2,389
839
841
257
310
Methamphetamine3
776
821
190
208
65
85
Sedatives
285
271
62
78
34
18
ILLICIT DRUGS OTHER THAN MARIJUANA1
8,182
8,153
3,711
3,647
1,453
1,459
140320
Table 1.6B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 21 to 25: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
60.6
60.2
34.2
34.2
19.7
20.9
Marijuana and Hashish
55.1
55.2
29.1
30.0
17.1
18.3
Cocaine
14.9
14.7
4.7
5.1
1.2
1.3
Crack
2.3
2.2
0.4
0.3
0.1
0.2
Heroin
2.4
2.3
0.9
0.9
0.4
0.3
Hallucinogens
19.9
20.3
5.4b
6.5
1.3
1.6
LSD
6.6a
7.6
1.4a
1.9
0.3
0.2
PCP
1.1
1.2
0.1
0.1
0.0
0.0
Ecstasy
14.4
14.9
3.4
3.9
0.8
1.0
Inhalants
9.0a
8.1
1.1
1.2
0.3
0.3
Nonmedical Use of Psychotherapeutics2,3
30.3
29.4
13.3
12.2
5.3
5.0
Pain Relievers
24.1
22.9
9.7a
8.7
3.8
3.4
OxyContin®
6.7
6.2
1.7
1.5
0.5
0.3
Tranquilizers
14.4
13.7
4.9
4.7
1.7
1.4
Stimulants3
11.3
11.1
3.9
3.9
1.2
1.4
Methamphetamine3
3.6
3.8
0.9
1.0
0.3
0.4
Sedatives
1.3
1.3
0.3
0.4
0.2
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
38.4
37.8
17.4
16.9
6.8
6.8
140320
Table 1.7A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
22,440
23,057
8,778
9,501
5,111
5,699
Marijuana and Hashish
20,367
21,263
6,706b
7,834
4,171
4,721
Cocaine
7,060
7,053
1,159
1,274
425
480
Crack
1,909
1,767
208
151
93
83
Heroin
965
1,151
219
249
111
119
Hallucinogens
8,487
8,766
896
917
196
238
LSD
4,648
4,653
157
174
16
41
PCP
851
728
46
13
11
*
Ecstasy
5,907
6,398
585
651
107
181
Inhalants
4,626
4,578
187
228
58
84
Nonmedical Use of Psychotherapeutics2,3
11,464
11,462
3,758
3,843
1,503
1,659
Pain Relievers
8,835
8,735
2,747
2,665
1,111
1,115
OxyContin®
2,112
2,389
352
386
150
107
Tranquilizers
5,518
5,671
1,563
1,523
504
521
Stimulants3
4,655
4,811
914
1,076
336
422
Methamphetamine3
2,704
2,531
370
295
153
159
Sedatives
577
804
137
175
29
86
ILLICIT DRUGS OTHER THAN MARIJUANA1
15,346
15,592
4,727
4,770
1,891
2,109
140320
Table 1.7B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 to 34: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
60.8
61.7
23.8
25.4
13.8
15.3
Marijuana and Hashish
55.2
56.9
18.2b
21.0
11.3
12.6
Cocaine
19.1
18.9
3.1
3.4
1.2
1.3
Crack
5.2
4.7
0.6
0.4
0.3
0.2
Heroin
2.6
3.1
0.6
0.7
0.3
0.3
Hallucinogens
23.0
23.5
2.4
2.5
0.5
0.6
LSD
12.6
12.5
0.4
0.5
0.0
0.1
PCP
2.3
1.9
0.1
0.0
0.0
*
Ecstasy
16.0
17.1
1.6
1.7
0.3
0.5
Inhalants
12.5
12.3
0.5
0.6
0.2
0.2
Nonmedical Use of Psychotherapeutics2,3
31.1
30.7
10.2
10.3
4.1
4.4
Pain Relievers
23.9
23.4
7.4
7.1
3.0
3.0
OxyContin®
5.7
6.4
1.0
1.0
0.4
0.3
Tranquilizers
14.9
15.2
4.2
4.1
1.4
1.4
Stimulants3
12.6
12.9
2.5
2.9
0.9
1.1
Methamphetamine3
7.3
6.8
1.0
0.8
0.4
0.4
Sedatives
1.6
2.2
0.4
0.5
0.1
0.2
ILLICIT DRUGS OTHER THAN MARIJUANA1
41.6
41.7
12.8
12.8
5.1
5.6
140320
Table 1.8A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
76,347
78,781
15,683
15,355
8,994
9,186
Marijuana and Hashish
68,588a
71,305
10,557
10,772
6,399
6,691
Cocaine
26,096
26,324
1,731a
1,233
798
628
Crack
6,418
6,517
554
376
312
255
Heroin
2,877
3,004
147
157
85
66
Hallucinogens
22,496
24,145
620
693
178
324
LSD
16,782
17,651
125
79
24
31
PCP
5,260
5,362
21
22
*
22
Ecstasy
5,315b
6,611
325
326
87
110
Inhalants
11,938
12,551
386
347
125
185
Nonmedical Use of Psychotherapeutics2,3
30,734
30,283
6,538
5,819
2,802
2,615
Pain Relievers
18,383
17,682
4,903
4,199
1,882
1,849
OxyContin®
2,134
2,421
371
433
15b
249
Tranquilizers
12,998
13,065
2,340a
1,831
958
659
Stimulants3
12,974
13,129
718
841
318
397
Methamphetamine3
8,321
8,565
362
500
159
294
Sedatives
6,766
6,112
253
261
163
105
ILLICIT DRUGS OTHER THAN MARIJUANA1
46,781
47,353
8,026
7,265
3,640
3,462
140320
Table 1.8B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 35 or Older: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
46.7
47.6
9.6
9.3
5.5
5.6
Marijuana and Hashish
41.9
43.1
6.5
6.5
3.9
4.0
Cocaine
15.9
15.9
1.1a
0.7
0.5
0.4
Crack
3.9
3.9
0.3
0.2
0.2
0.2
Heroin
1.8
1.8
0.1
0.1
0.1
0.0
Hallucinogens
13.7
14.6
0.4
0.4
0.1
0.2
LSD
10.3
10.7
0.1
0.0
0.0
0.0
PCP
3.2
3.2
0.0
0.0
*
0.0
Ecstasy
3.2b
4.0
0.2
0.2
0.1
0.1
Inhalants
7.3
7.6
0.2
0.2
0.1
0.1
Nonmedical Use of Psychotherapeutics2,3
18.8
18.3
4.0
3.5
1.7
1.6
Pain Relievers
11.2
10.7
3.0a
2.5
1.2
1.1
OxyContin®
1.3
1.5
0.2
0.3
0.0b
0.2
Tranquilizers
7.9
7.9
1.4a
1.1
0.6
0.4
Stimulants3
7.9
7.9
0.4
0.5
0.2
0.2
Methamphetamine3
5.1
5.2
0.2
0.3
0.1
0.2
Sedatives
4.1
3.7
0.2
0.2
0.1
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
28.6
28.6
4.9
4.4
2.2
2.1
140320
Table 1.9A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
66,653
67,412
23,794
23,694
14,612
14,671
Marijuana and Hashish
60,056
61,743
19,193
19,713
12,085
12,300
Cocaine
22,757
22,612
3,298
2,855
1,231
1,038
Crack
6,214
5,504
699b
390
329
218
Heroin
3,221
3,110
478
448
256
173
Hallucinogens
22,941
23,835
2,792
2,809
715
902
LSD
15,230
15,592
747
726
111
156
PCP
4,483
4,116
117
52
24
7
Ecstasy
9,478
10,040
1,628
1,554
366
439
Inhalants
13,953
13,675
1,052
1,025
335
342
Nonmedical Use of Psychotherapeutics2,3
29,080a
27,490
8,663a
7,772
3,565
3,340
Pain Relievers
20,826b
18,918
6,851b
5,834
2,646
2,398
OxyContin®
4,107
4,207
938
948
258
337
Tranquilizers
12,208
11,942
2,980
2,602
1,054
833
Stimulants3
11,962
11,872
1,782
1,831
639
742
Methamphetamine3
7,534
7,366
718
793
242
432
Sedatives
4,653
4,176
202
286
133
121
ILLICIT DRUGS OTHER THAN MARIJUANA1
43,438
42,406
11,826a
10,870
5,060
4,855
140320
Table 1.9B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Males Aged 12 or Older: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
52.9
53.0
18.9
18.6
11.6
11.5
Marijuana and Hashish
47.7
48.6
15.2
15.5
9.6
9.7
Cocaine
18.1
17.8
2.6
2.2
1.0
0.8
Crack
4.9
4.3
0.6b
0.3
0.3
0.2
Heroin
2.6
2.4
0.4
0.4
0.2
0.1
Hallucinogens
18.2
18.7
2.2
2.2
0.6
0.7
LSD
12.1
12.3
0.6
0.6
0.1
0.1
PCP
3.6
3.2
0.1
0.0
0.0
0.0
Ecstasy
7.5
7.9
1.3
1.2
0.3
0.3
Inhalants
11.1
10.8
0.8
0.8
0.3
0.3
Nonmedical Use of Psychotherapeutics2,3
23.1a
21.6
6.9a
6.1
2.8
2.6
Pain Relievers
16.5b
14.9
5.4b
4.6
2.1
1.9
OxyContin®
3.3
3.3
0.7
0.7
0.2
0.3
Tranquilizers
9.7
9.4
2.4
2.0
0.8
0.7
Stimulants3
9.5
9.3
1.4
1.4
0.5
0.6
Methamphetamine3
6.0
5.8
0.6
0.6
0.2
0.3
Sedatives
3.7
3.3
0.2
0.2
0.1
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
34.5
33.4
9.4a
8.6
4.0
3.8
140320
Table 1.10A – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Numbers in Thousands, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
58,155a
60,046
17,685
17,897
9,251
9,903
Marijuana and Hashish
51,183
52,969
12,320
13,239
6,770
7,510
Cocaine
14,931
15,022
1,372
1,327
419
511
Crack
2,801a
3,366
222
242
115
160
Heroin
1,344
1,703
191
233
79
116
Hallucinogens
14,967
15,902
1,514
1,621
419
431
LSD
8,505
9,178
310
386
73
73
PCP
2,070
2,346
56
38
8
26
Ecstasy
6,683b
7,774
981
1,034
261
221
Inhalants
7,142
7,393
641a
508
157
153
Nonmedical Use of Psychotherapeutics2,3
25,309
25,682
8,003
7,576
3,266
3,144
Pain Relievers
16,219
16,555
5,638
5,248
2,216
2,123
OxyContin®
2,472
2,766
538
495
100
155
Tranquilizers
11,430
11,551
3,093
2,667
1,085
872
Stimulants3
9,536
9,784
1,534
1,661
532
623
Methamphetamine3
4,725
4,890
437
393
197
163
Sedatives
3,286
3,304
388
353
137
130
ILLICIT DRUGS OTHER THAN MARIJUANA1
34,596
35,670
9,441
8,997
3,823
3,810
140320
Table 1.10B – Types of Illicit Drug Use in Lifetime, Past Year, and Past Month among Females Aged 12 or Older: Percentages, 2012 and 2013
Drug
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. Illicit Drugs Other Than Marijuana include cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically. The estimates for Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine incorporated in these summary estimates do not include data from new methamphetamine items added in 2005 and 2006. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. 2 Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. 3 Estimates of Nonmedical Use of Psychotherapeutics, Stimulants, and Methamphetamine in the designated rows include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
ILLICIT DRUGS1
43.3
44.4
13.2
13.2
6.9
7.3
Marijuana and Hashish
38.1
39.2
9.2
9.8
5.0
5.6
Cocaine
11.1
11.1
1.0
1.0
0.3
0.4
Crack
2.1
2.5
0.2
0.2
0.1
0.1
Heroin
1.0
1.3
0.1
0.2
0.1
0.1
Hallucinogens
11.2
11.8
1.1
1.2
0.3
0.3
LSD
6.3
6.8
0.2
0.3
0.1
0.1
PCP
1.5
1.7
0.0
0.0
0.0
0.0
Ecstasy
5.0b
5.7
0.7
0.8
0.2
0.2
Inhalants
5.3
5.5
0.5a
0.4
0.1
0.1
Nonmedical Use of Psychotherapeutics2,3
18.9
19.0
6.0
5.6
2.4
2.3
Pain Relievers
12.1
12.2
4.2
3.9
1.7
1.6
OxyContin®
1.8
2.0
0.4
0.4
0.1
0.1
Tranquilizers
8.5
8.5
2.3
2.0
0.8
0.6
Stimulants3
7.1
7.2
1.1
1.2
0.4
0.5
Methamphetamine3
3.5
3.6
0.3
0.3
0.1
0.1
Sedatives
2.4
2.4
0.3
0.3
0.1
0.1
ILLICIT DRUGS OTHER THAN MARIJUANA1
25.8
26.4
7.0
6.7
2.8
2.8
140320
Table 1.11A – Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
124,808
127,458
41,479
41,591
23,863
24,573
12
327
299
204
191
100
87
13
518
473
355a
275
184b
119
14
802
802
557
567
285
291
15
1,134
1,060
811
776
399
373
16
1,464
1,439
1,154
1,127
620
646
17
1,800
1,721
1,387
1,350
789a
680
18
2,322
2,258
1,805
1,765
1,061
993
19
2,221
2,120
1,625
1,591
1,034
948
20
2,513
2,441
1,829
1,705
1,079
1,036
21
2,598
2,524
1,665
1,646
946
1,022
22
2,710
2,633
1,674
1,558
1,004
980
23
2,665
2,708
1,409
1,455
793
847
24
2,505
2,646
1,339
1,460
782a
921
25
2,444
2,496
1,205
1,268
683
742
26-29
10,587
10,631
4,529
4,808
2,506
2,743
30-34
11,853
12,425
4,248
4,692
2,605
2,957
35-39
10,781
10,149
3,048
2,826
1,718
1,780
40-44
10,998
11,565
2,775
2,855
1,471
1,649
45-49
12,626
11,631
2,862
2,578
1,640
1,454
50-54
14,212
14,530
2,829
2,877
1,681
1,812
55-59
11,686
11,704
2,216
1,757
1,355
1,165
60-64
7,972
8,861
1,010
1,150
604
692
65 or Older
8,073b
10,340
943
1,311
525
634
140320
Table 1.11B – Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
48.0
48.6
16.0
15.9
9.2
9.4
12
8.1
8.0
5.0
5.1
2.5
2.3
13
12.9
11.2
8.8b
6.5
4.6b
2.8
14
19.1
18.3
13.3
12.9
6.8
6.6
15
27.1
25.6
19.3
18.8
9.5
9.0
16
34.8
33.7
27.5
26.4
14.7
15.1
17
42.1
41.7
32.4
32.7
18.4
16.5
18
49.3
47.7
38.4
37.3
22.5
21.0
19
52.2
50.9
38.2
38.2
24.3
22.8
20
58.3
56.8
42.4
39.7
25.0
24.1
21
58.8
59.6
37.7
38.8
21.4
24.1
22
60.9
58.8
37.6
34.8
22.6
21.9
23
61.0
61.9
32.2
33.2
18.1
19.4
24
61.3
60.2
32.8
33.2
19.2
21.0
25
61.2
60.7
30.2
30.9
17.1
18.1
26-29
61.7
61.8
26.4
27.9
14.6
15.9
30-34
60.0
61.7
21.5
23.3
13.2
14.7
35-39
55.5
53.3
15.7
14.8
8.8
9.3
40-44
54.5
53.9
13.8
13.3
7.3
7.7
45-49
59.0
58.2
13.4
12.9
7.7
7.3
50-54
60.7
63.0
12.1
12.5
7.2
7.9
55-59
56.8
57.0
10.8
8.6
6.6
5.7
60-64
47.6
49.8
6.0
6.5
3.6
3.9
65 or Older
19.3b
23.8
2.3
3.0
1.3
1.5
140320
Table 1.12A – Marijuana Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
111,239a
114,712
31,513
32,952
18,855
19,810
12
57
72
44
59
9
21
13
204
168
164
138
84
60
14
437
445
352
371
183
196
15
788
765
615
604
332
296
16
1,205
1,182
968
974
508
568
17
1,540
1,460
1,219
1,200
684
621
18
2,040
2,004
1,609
1,566
940
897
19
1,963
1,906
1,465
1,436
939
873
20
2,301
2,226
1,609
1,523
968
915
21
2,337
2,338
1,468
1,486
831
919
22
2,477
2,420
1,429
1,350
856
860
23
2,438
2,448
1,209
1,244
687
734
24
2,282
2,435
1,129
1,285
684
788
25
2,214
2,274
969
1,111
579
650
26-29
9,635
9,816
3,447
3,984
2,041
2,363
30-34
10,732
11,447
3,259a
3,849
2,130
2,358
35-39
9,651
9,075
2,099
1,997
1,291
1,332
40-44
9,642
10,049
1,836
2,008
1,027
1,208
45-49
11,507
10,658
2,008
1,740
1,119
1,044
50-54
13,271
13,787
1,866
2,215
1,198
1,272
55-59
10,913
10,965
1,517
1,347
986
910
60-64
7,427
8,264
739
842
404
548
65 or Older
6,177b
8,508
494
623
375
377
140320
Table 1.12B – Marijuana Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
42.8
43.7
12.1
12.6
7.3
7.5
12
1.4
1.9
1.1
1.6
0.2
0.6
13
5.1
4.0
4.1
3.3
2.1
1.4
14
10.4
10.2
8.4
8.5
4.4
4.5
15
18.8
18.5
14.7
14.6
7.9
7.1
16
28.7
27.7
23.0
22.8
12.1
13.3
17
36.0
35.4
28.5
29.1
16.0
15.0
18
43.3
42.3
34.2
33.1
20.0
18.9
19
46.1
45.7
34.4
34.5
22.1
20.9
20
53.4
51.8
37.3
35.5
22.5
21.3
21
52.9
55.2
33.2
35.1
18.8
21.7
22
55.7
54.1
32.1
30.2
19.3
19.2
23
55.8
55.9
27.7
28.4
15.7
16.8
24
55.9
55.4
27.6
29.3
16.7
18.0
25
55.4
55.3
24.3
27.0
14.5
15.8
26-29
56.2
57.0
20.1a
23.1
11.9
13.7
30-34
54.3
56.9
16.5a
19.1
10.8
11.7
35-39
49.6
47.6
10.8
10.5
6.6
7.0
40-44
47.8
46.8
9.1
9.4
5.1
5.6
45-49
53.7
53.3
9.4
8.7
5.2
5.2
50-54
56.7
59.7
8.0
9.6
5.1
5.5
55-59
53.0
53.4
7.4
6.6
4.8
4.4
60-64
44.4
46.5
4.4
4.7
2.4
3.1
65 or Older
14.8b
19.6
1.2
1.4
0.9
0.9
140320
Table 1.13A – Cocaine Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
37,688
37,634
4,671
4,182
1,650
1,549
12
3
3
2
3
1
*
13
8
6
8
4
*
2
14
20
10
13
8
1
8
15
39
27
21
18
8
4
16
64
68
47
37
5
10
17
132
101
90
62
15
20
18
279a
186
168
115
54
33
19
346
283
191
159
41
46
20
457
405
235
176
45
45
21
535
452
201
208
46
47
22
639
649
260
262
78
79
23
656
680
203
228
53
40
24
700
727
164
227
38
56
25
655
658
179
169
42
52
26-29
3,330
3,158
608
615
174
189
30-34
3,730
3,895
551
660
250
292
35-39
3,220
2,707
386
319
167
132
40-44
3,774
3,632
330a
167
120
68
45-49
5,356a
4,649
412a
216
211
103
50-54
6,281
6,849
231
294
109
181
55-59
4,258
4,125
256
113
117
48
60-64
2,093
2,669
116
99
73
73
65 or Older
1,115a
1,693
*
26
*
22
140320
Table 1.13B – Cocaine Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
14.5
14.3
1.8
1.6
0.6
0.6
12
0.1
0.1
0.1
0.1
0.0
*
13
0.2
0.1
0.2
0.1
*
0.0
14
0.5
0.2
0.3
0.2
0.0
0.2
15
0.9
0.6
0.5
0.4
0.2
0.1
16
1.5
1.6
1.1
0.9
0.1
0.2
17
3.1
2.5
2.1
1.5
0.4
0.5
18
5.9b
3.9
3.6
2.4
1.2
0.7
19
8.1
6.8
4.5
3.8
1.0
1.1
20
10.6
9.4
5.5
4.1
1.0
1.0
21
12.1
10.7
4.6
4.9
1.1
1.1
22
14.4
14.5
5.8
5.8
1.8
1.8
23
15.0
15.5
4.6
5.2
1.2
0.9
24
17.1
16.5
4.0
5.2
0.9
1.3
25
16.4
16.0
4.5
4.1
1.1
1.3
26-29
19.4
18.4
3.5
3.6
1.0
1.1
30-34
18.9
19.3
2.8
3.3
1.3
1.4
35-39
16.6
14.2
2.0
1.7
0.9
0.7
40-44
18.7
16.9
1.6a
0.8
0.6
0.3
45-49
25.0
23.3
1.9a
1.1
1.0
0.5
50-54
26.8
29.7
1.0
1.3
0.5
0.8
55-59
20.7
20.1
1.2
0.5
0.6
0.2
60-64
12.5
15.0
0.7
0.6
0.4
0.4
65 or Older
2.7a
3.9
*
0.1
*
0.1
140320
Table 1.14A – Crack Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
9,015
8,870
921a
632
443
377
12
*
*
*
*
*
*
13
1
2
0
2
*
2
14
2
1
1
*
*
*
15
8
5
3
2
*
*
16
12
6
7
3
1
*
17
12
9
7
4
*
1
18
39
29
17
8
7
2
19
48
27
20
10
2
2
20
67
40
27a
6
5
*
21
59
49
12
11
5
6
22
91a
54
17
11
5
5
23
113
111
11
10
3
1
24
116
119
19
9
7
3
25
121
134
16
30
3
17
26-29
717
809
79
49
15
17
30-34
1,192
957
129
101
78
67
35-39
918
784
73
35
53
20
40-44
1,126
939
88
44
27
37
45-49
1,467
1,217
172a
40
97
21
50-54
1,455
1,760
117
121
57
103
55-59
836
1,128
71
81
60
24
60-64
484
386
32
29
17
29
65 or Older
132
303
*
26
*
21
140320
Table 1.14B – Crack Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
3.5
3.4
0.4a
0.2
0.2
0.1
12
*
*
*
*
*
*
13
0.0
0.0
0.0
0.0
*
0.0
14
0.0
0.0
0.0
*
*
*
15
0.2
0.1
0.1
0.1
*
*
16
0.3
0.1
0.2
0.1
0.0
*
17
0.3
0.2
0.2
0.1
*
0.0
18
0.8
0.6
0.4
0.2
0.2
0.0
19
1.1
0.7
0.5
0.2
0.0
0.1
20
1.6
0.9
0.6a
0.1
0.1
*
21
1.3
1.2
0.3
0.3
0.1
0.2
22
2.0a
1.2
0.4
0.3
0.1
0.1
23
2.6
2.5
0.3
0.2
0.1
0.0
24
2.8
2.7
0.5
0.2
0.2
0.1
25
3.0
3.3
0.4
0.7
0.1
0.4
26-29
4.2
4.7
0.5
0.3
0.1
0.1
30-34
6.0
4.8
0.7
0.5
0.4
0.3
35-39
4.7
4.1
0.4
0.2
0.3
0.1
40-44
5.6
4.4
0.4
0.2
0.1
0.2
45-49
6.8
6.1
0.8a
0.2
0.5
0.1
50-54
6.2
7.6
0.5
0.5
0.2
0.4
55-59
4.1
5.5
0.3
0.4
0.3
0.1
60-64
2.9
2.2
0.2
0.2
0.1
0.2
65 or Older
0.3
0.7
*
0.1
*
0.0
140320
Table 1.15A – Hallucinogen Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
37,908
39,736
4,306
4,430
1,134
1,333
12
14
25
8
16
6
3
13
35
34
25
19
13
8
14
89a
54
61
38
17
18
15
127
97
87
61
24
19
16
220
200
171
140
45
32
17
339
293
200
208
54
74
18
551
486
344
305
137
123
19
586
564
375
309
105
93
20
721
687
371
313
78
65
21
776
785
277
357
71
65
22
909
908
273
333
75
88
23
858
936
224
303
69
62
24
857
975
188
251
34a
79
25
845
783
184
167
31
42
26-29
3,833
3,863
545
473
110
147
30-34
4,653
4,903
351
444
85
90
35-39
3,895
3,741
249
218
56
117
40-44
3,173a
3,778
82
153
21
21
45-49
3,885
3,395
112
57
49
12
50-54
4,332
5,215
35
87
35
77
55-59
3,822
3,804
16
8
4
*
60-64
2,229
2,542
69
13
*
*
65 or Older
1,159
1,671
57
157
13
97
140320
Table 1.15B – Hallucinogen Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
14.6
15.1
1.7
1.7
0.4
0.5
12
0.4
0.7
0.2
0.4
0.2
0.1
13
0.9
0.8
0.6
0.5
0.3
0.2
14
2.1a
1.2
1.5
0.9
0.4
0.4
15
3.0
2.4
2.1
1.5
0.6
0.5
16
5.2
4.7
4.1
3.3
1.1
0.7
17
7.9
7.1
4.7
5.0
1.3
1.8
18
11.7
10.3
7.3
6.4
2.9
2.6
19
13.8
13.5
8.8
7.4
2.5
2.2
20
16.7
16.0
8.6
7.3
1.8
1.5
21
17.6
18.5
6.3a
8.4
1.6
1.5
22
20.4
20.3
6.1
7.4
1.7
2.0
23
19.6
21.4
5.1a
6.9
1.6
1.4
24
21.0
22.2
4.6
5.7
0.8a
1.8
25
21.2
19.1
4.6
4.1
0.8
1.0
26-29
22.3
22.4
3.2
2.7
0.6
0.9
30-34
23.6
24.4
1.8
2.2
0.4
0.4
35-39
20.0
19.6
1.3
1.1
0.3
0.6
40-44
15.7
17.6
0.4
0.7
0.1
0.1
45-49
18.1
17.0
0.5
0.3
0.2
0.1
50-54
18.5a
22.6
0.1
0.4
0.1
0.3
55-59
18.6
18.5
0.1
0.0
0.0
*
60-64
13.3
14.3
0.4
0.1
*
*
65 or Older
2.8
3.8
0.1
0.4
0.0
0.2
140320
Table 1.16A – Inhalant Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
21,095
21,068
1,693
1,533
493
496
12
172
139
73
71
31
27
13
222
197
104
74
43a
20
14
316
265
142a
90
38
18
15
324
287
108
107
18
31
16
296a
215
125b
63
27
12
17
283a
224
95
76
31
13
18
358
280
107
74
28
16
19
312
277
68
66
16
15
20
325
309
64
78
16
20
21
350
341
88
84
35
16
22
399
376
56
54
12
17
23
386
367
30
48
8
6
24
374
386
15a
45
1
7
25
413b
277
45
30
7
10
26-29
1,891
1,809
121
113
39
22
30-34
2,735
2,768
66
115
18
62
35-39
2,180
2,108
94
43
14
19
40-44
2,275
2,299
90
77
5
51
45-49
2,097
2,167
117
74
43
55
50-54
1,951b
2,888
39
50
26
31
55-59
1,878
1,391
37
93
37
19
60-64
762
971
9
7
*
7
65 or Older
795
727
*
3
*
3
140320
Table 1.16B – Inhalant Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
8.1
8.0
0.7
0.6
0.2
0.2
12
4.2
3.7
1.8
1.9
0.8
0.7
13
5.5
4.7
2.6
1.7
1.1a
0.5
14
7.5
6.0
3.4b
2.0
0.9a
0.4
15
7.7
6.9
2.6
2.6
0.4
0.8
16
7.0b
5.0
3.0b
1.5
0.6
0.3
17
6.6
5.4
2.2
1.8
0.7
0.3
18
7.6
5.9
2.3
1.6
0.6
0.3
19
7.3
6.7
1.6
1.6
0.4
0.4
20
7.5
7.2
1.5
1.8
0.4
0.5
21
7.9
8.0
2.0
2.0
0.8
0.4
22
9.0
8.4
1.3
1.2
0.3
0.4
23
8.8
8.4
0.7
1.1
0.2
0.1
24
9.2
8.8
0.4a
1.0
0.0
0.2
25
10.3b
6.7
1.1
0.7
0.2
0.2
26-29
11.0
10.5
0.7
0.7
0.2
0.1
30-34
13.8
13.7
0.3
0.6
0.1
0.3
35-39
11.2
11.1
0.5
0.2
0.1
0.1
40-44
11.3
10.7
0.4
0.4
0.0
0.2
45-49
9.8
10.8
0.5
0.4
0.2
0.3
50-54
8.3b
12.5
0.2
0.2
0.1
0.1
55-59
9.1
6.8
0.2
0.5
0.2
0.1
60-64
4.6
5.5
0.1
0.0
*
0.0
65 or Older
1.9
1.7
*
0.0
*
0.0
140320
Table 1.17A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
54,389
53,172
16,666a
15,348
6,831
6,484
12
164
130
119
88
66
50
13
219
199
149a
99
70
50
14
305
338
198
229
100
96
15
469b
356
302
248
114
89
16
580
549
394
371
159
140
17
745a
615
479
406
185a
124
18
1,037
904
634
527
224
182
19
990
871
556
490
217
165
20
1,213
1,117
701
584
252
236
21
1,211
1,178
563
589
204
227
22
1,405
1,289
743a
603
297
234
23
1,328
1,340
546
535
235
243
24
1,266
1,324
525
507
205
215
25
1,259
1,216
460
409
198
159
26-29
5,650
5,448
1,951
1,877
730
745
30-34
5,814
6,014
1,807
1,966
773
913
35-39
4,791
4,593
1,304
1,185
559
493
40-44
4,623
4,765
1,296
1,113
516
590
45-49
5,329b
4,319
1,074
1,026
445
419
50-54
5,912
6,168
1,289
967
564
482
55-59
4,774
3,999
832
542
380
247
60-64
2,654
2,792
300
324
200
95
65 or Older
2,652a
3,648
442
662
137
290
140320
Table 1.17B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
20.9
20.3
6.4a
5.8
2.6
2.5
12
4.0
3.5
3.0
2.3
1.6
1.3
13
5.5
4.7
3.7b
2.3
1.7
1.2
14
7.2
7.7
4.7
5.2
2.4
2.2
15
11.2b
8.6
7.2
6.0
2.7
2.1
16
13.8
12.8
9.4
8.7
3.8
3.3
17
17.4a
14.9
11.2
9.8
4.3a
3.0
18
22.0a
19.1
13.5a
11.1
4.8
3.9
19
23.3
20.9
13.1
11.8
5.1
4.0
20
28.1
26.0
16.3
13.6
5.8
5.5
21
27.4
27.8
12.7
13.9
4.6
5.4
22
31.6
28.8
16.7a
13.5
6.7
5.2
23
30.4
30.6
12.5
12.2
5.4
5.5
24
31.0
30.1
12.8
11.6
5.0
4.9
25
31.5
29.6
11.5
9.9
5.0
3.9
26-29
32.9
31.7
11.4
10.9
4.3
4.3
30-34
29.4
29.9
9.1
9.8
3.9
4.5
35-39
24.6
24.1
6.7
6.2
2.9
2.6
40-44
22.9
22.2
6.4
5.2
2.6
2.7
45-49
24.9a
21.6
5.0
5.1
2.1
2.1
50-54
25.3
26.7
5.5
4.2
2.4
2.1
55-59
23.2a
19.5
4.0
2.6
1.8
1.2
60-64
15.9
15.7
1.8
1.8
1.2
0.5
65 or Older
6.3a
8.4
1.1
1.5
0.3
0.7
140320
Table 1.18A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month, by Detailed Age Category: Numbers in Thousands, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
37,045
35,473
12,489b
11,082
4,862
4,521
12
147a
99
107a
64
59
34
13
185
168
125
86
59
42
14
246
294
162
198
88
88
15
383a
296
247
204
93
70
16
497
450
329
297
134
106
17
611a
499
362
308
124a
87
18
871a
705
499a
392
171a
116
19
772
702
410
362
148
100
20
979
895
528
425
190
174
21
957
926
361
407
137
144
22
1,134
1,039
550
440
208
155
23
1,031
1,066
410
377
167
183
24
1,020
1,014
394
357
138
148
25
996
904
354
300
152
113
26-29
4,498
4,092
1,459
1,266
559
484
30-34
4,337
4,643
1,288
1,400
551
631
35-39
3,586
3,291
994
854
397
344
40-44
3,273
3,373
997
847
382
414
45-49
3,255a
2,660
810
708
346
306
50-54
3,269
3,185
919
769
348
318
55-59
2,694a
2,043
613
392
163
133
60-64
1,259
1,445
233
196
135
69
65 or Older
1,047a
1,687
336
432
111
264
140320
Table 1.18B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2012 and 2013
Age Category
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
14.2a
13.5
4.8b
4.2
1.9
1.7
12
3.6
2.6
2.7a
1.7
1.5
0.9
13
4.6
4.0
3.1a
2.0
1.5
1.0
14
5.9
6.7
3.9
4.5
2.1
2.0
15
9.1a
7.2
5.9
4.9
2.2
1.7
16
11.8
10.5
7.8
6.9
3.2
2.5
17
14.3a
12.1
8.5
7.5
2.9
2.1
18
18.5b
14.9
10.6a
8.3
3.6a
2.4
19
18.1
16.8
9.6
8.7
3.5
2.4
20
22.7
20.8
12.3
9.9
4.4
4.0
21
21.7
21.8
8.2
9.6
3.1
3.4
22
25.5
23.2
12.4a
9.8
4.7
3.5
23
23.6
24.3
9.4
8.6
3.8
4.2
24
25.0
23.1
9.6
8.1
3.4
3.4
25
24.9
22.0
8.9
7.3
3.8
2.7
26-29
26.2
23.8
8.5
7.4
3.3
2.8
30-34
22.0
23.1
6.5
7.0
2.8
3.1
35-39
18.4
17.3
5.1
4.5
2.0
1.8
40-44
16.2
15.7
4.9
3.9
1.9
1.9
45-49
15.2
13.3
3.8
3.5
1.6
1.5
50-54
14.0
13.8
3.9
3.3
1.5
1.4
55-59
13.1a
9.9
3.0
1.9
0.8
0.6
60-64
7.5
8.1
1.4
1.1
0.8
0.4
65 or Older
2.5a
3.9
0.8
1.0
0.3
0.6
140320
Table 1.19A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
124,808
127,458
41,479
41,591
23,863
24,573
AGE
12-17
6,044
5,794
4,468
4,287
2,377a
2,197
18-25
19,977
19,826
12,551
12,448
7,381
7,490
26 or Older
98,787a
101,838
24,460
24,856
14,105
14,886
GENDER
Male
66,653
67,412
23,794
23,694
14,612
14,671
Female
58,155a
60,046
17,685
17,897
9,251
9,903
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
108,371a
111,317
35,163
35,368
20,520
20,930
White
87,569a
89,899
27,018
27,450
15,678
16,204
Black or African American
14,268
14,784
5,731
5,240
3,479
3,274
American Indian or Alaska Native
929
853
357
375
184
173
Native Hawaiian or Other Pacific Islander
*
420
201
181
84
122
Asian
2,912
2,860
953
942
479
410
Two or More Races
2,207
2,500
903a
1,179
616
748
Hispanic or Latino
16,437
16,141
6,317
6,222
3,343
3,643
140320
Table 1.19B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
48.0
48.6
16.0
15.9
9.2
9.4
AGE
12-17
24.2
23.3
17.9
17.2
9.5a
8.8
18-25
57.8
57.0
36.3
35.8
21.3
21.5
26 or Older
49.3
50.2
12.2
12.3
7.0
7.3
GENDER
Male
52.9
53.0
18.9
18.6
11.6
11.5
Female
43.3
44.4
13.2
13.2
6.9
7.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
49.3
50.3
16.0
16.0
9.3
9.5
White
51.6
52.9
15.9
16.1
9.2
9.5
Black or African American
46.5
47.3
18.7a
16.8
11.3
10.5
American Indian or Alaska Native
64.3
60.9
24.7
26.8
12.7
12.3
Native Hawaiian or Other Pacific Islander
*
48.3
18.6
20.8
7.8
14.0
Asian
22.8
21.4
7.5
7.1
3.7
3.1
Two or More Races
53.1
58.3
21.7a
27.5
14.8
17.4
Hispanic or Latino
40.8
39.1
15.7
15.1
8.3
8.8
140320
Table 1.20A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
6,044
5,794
4,468
4,287
2,377a
2,197
GENDER
Male
3,123
3,056
2,268
2,263
1,217
1,220
Female
2,921a
2,738
2,201a
2,023
1,160b
977
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
4,602
4,476
3,454
3,329
1,843
1,715
White
3,226
3,031
2,484
2,315
1,318
1,196
Black or African American
957
963
673
691
358
361
American Indian or Alaska Native
49
62
33
44
18
*
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
*
Asian
116a
190
72
113
31
47
Two or More Races
221
193
171
143
108
78
Hispanic or Latino
1,443
1,318
1,014
958
533
482
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic
1,683
1,595
1,268
1,215
696
660
Female, White, Not Hispanic
1,542
1,437
1,216
1,100
622
536
Male, Black, Not Hispanic
490
498
333
352
173
209
Female, Black, Not Hispanic
467
465
340
339
185
151
Male, Hispanic
725
710
518
536
267
267
Female, Hispanic
717
608
496
422
266
215
140320
Table 1.20B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
24.2
23.3
17.9
17.2
9.5a
8.8
GENDER
Male
24.5
24.1
17.8
17.8
9.6
9.6
Female
24.0
22.5
18.0a
16.6
9.5b
8.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
23.7
23.2
17.8
17.2
9.5
8.9
White
23.5
22.2
18.1
17.0
9.6
8.8
Black or African American
27.1
28.0
19.1
20.1
10.2
10.5
American Indian or Alaska Native
32.7
38.7
22.2
27.8
12.1
*
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
*
Asian
9.8a
15.2
6.1
9.1
2.6
3.8
Two or More Races
30.1
25.7
23.3
19.0
14.7a
10.3
Hispanic or Latino
26.3
23.7
18.5
17.2
9.7
8.7
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic
23.9
22.9
18.0
17.5
9.9
9.5
Female, White, Not Hispanic
23.0
21.5
18.1
16.5
9.3
8.0
Male, Black, Not Hispanic
27.4
28.4
18.6
20.1
9.7
11.9
Female, Black, Not Hispanic
26.8
27.5
19.6
20.1
10.6
9.0
Male, Hispanic
25.8
25.0
18.4
18.9
9.5
9.4
Female, Hispanic
26.7a
22.3
18.5
15.5
9.9
7.9
140320
Table 1.21A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
19,977
19,826
12,551
12,448
7,381
7,490
GENDER
Male
10,597
10,571
7,020
7,097
4,406
4,522
Female
9,379
9,255
5,530
5,351
2,976
2,969
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
16,216
16,003
10,390
10,194
6,169
6,171
White
12,066
11,897
7,591
7,577
4,424
4,650
Black or African American
2,719
2,682
1,865
1,719
1,224a
1,047
American Indian or Alaska Native
187
150
*
87
48
48
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
38
Asian
650
673
391
419
198
193
Two or More Races
510
490
351
335
236
195
Hispanic or Latino
3,761
3,824
2,161
2,254
1,212
1,319
EDUCATION
< High School
3,076
3,168
2,068
2,119
1,331
1,407
High School Graduate
6,574
6,615
4,151
4,179
2,610
2,496
Some College
7,375
7,065
4,685
4,454
2,672
2,713
College Graduate
2,952
2,978
1,647
1,696
769
874
CURRENT EMPLOYMENT
Full-Time
8,159
8,283
4,642
4,713
2,744
2,769
Part-Time
5,526
5,439
3,674
3,726
2,153
2,262
Unemployed
2,585
2,564
1,852
1,832
1,174
1,147
Other1
3,706
3,541
2,382
2,177
1,310
1,313
140320
Table 1.21B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
57.8
57.0
36.3
35.8
21.3
21.5
GENDER
Male
61.1
60.5
40.5
40.6
25.4
25.9
Female
54.4
53.4
32.1
30.9
17.3
17.1
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
59.1
58.1
37.9
37.0
22.5
22.4
White
61.7
61.0
38.8
38.9
22.6
23.9
Black or African American
55.4
53.6
38.0a
34.3
24.9b
20.9
American Indian or Alaska Native
70.2
65.3
*
37.7
18.0
20.9
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
19.0
Asian
36.5
36.0
22.0
22.4
11.1
10.3
Two or More Races
67.0
66.9
46.1
45.7
31.0
26.6
Hispanic or Latino
52.7
52.7
30.3
31.1
17.0
18.2
EDUCATION
< High School
57.8
56.7
38.9
37.9
25.0
25.2
High School Graduate
55.8
55.3
35.2
34.9
22.1
20.9
Some College
59.7
58.0
37.9
36.6
21.6
22.3
College Graduate
57.6
59.0
32.1
33.6
15.0
17.3
CURRENT EMPLOYMENT
Full-Time
60.6
61.3
34.5
34.9
20.4
20.5
Part-Time
58.8a
56.3
39.1
38.5
22.9
23.4
Unemployed
62.9
61.7
45.1
44.1
28.6
27.6
Other1
48.7
47.5
31.3
29.2
17.2
17.6
140320
Table 1.22A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
98,787a
101,838
24,460
24,856
14,105
14,886
GENDER
Male
52,933
53,784
14,506
14,333
8,990
8,929
Female
45,854a
48,053
9,954
10,522
5,115a
5,957
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
87,554b
90,838
21,318
21,845
12,507
13,044
White
72,277
74,971
16,942
17,559
9,936
10,357
Black or African American
10,592
11,139
3,193
2,830
1,897
1,866
American Indian or Alaska Native
693
641
194
244
118
106
Native Hawaiian or Other Pacific Islander
*
*
*
*
35
*
Asian
2,146
1,998
491
410
250
169
Two or More Races
1,476
1,817
381a
702
272
475
Hispanic or Latino
11,234
10,999
3,142
3,010
1,598
1,842
EDUCATION
< High School
11,099a
9,790
3,996a
3,334
2,455
2,392
High School Graduate
27,440
27,323
6,834
6,721
4,189
4,411
Some College
27,791
28,846
6,791
6,767
3,697
4,120
College Graduate
32,457b
35,879
6,839a
8,033
3,764
3,963
CURRENT EMPLOYMENT
Full-Time
59,288
60,321
13,961
13,824
7,738
8,030
Part-Time
11,998a
13,353
3,145
3,719
1,953
2,352
Unemployed
6,143b
4,529
2,002
1,782
1,277
1,002
Other1
21,358a
23,635
5,352
5,530
3,137
3,502
140320
Table 1.22B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
49.3
50.2
12.2
12.3
7.0
7.3
GENDER
Male
55.2
55.5
15.1
14.8
9.4
9.2
Female
43.8
45.4
9.5
9.9
4.9
5.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
50.6a
52.1
12.3
12.5
7.2
7.5
White
53.0a
54.8
12.4
12.8
7.3
7.6
Black or African American
47.6
48.9
14.3
12.4
8.5
8.2
American Indian or Alaska Native
67.4
63.4
18.8
24.1
11.4
10.5
Native Hawaiian or Other Pacific Islander
*
*
*
*
4.4
*
Asian
21.9
19.5
5.0
4.0
2.5
1.7
Two or More Races
55.5
64.8
14.3b
25.0
10.2
17.0
Hispanic or Latino
40.6
38.7
11.4
10.6
5.8
6.5
EDUCATION
< High School
38.4
36.8
13.8
12.5
8.5
9.0
High School Graduate
47.4
47.1
11.8
11.6
7.2
7.6
Some College
55.3
56.3
13.5
13.2
7.4
8.0
College Graduate
51.1a
53.6
10.8
12.0
5.9
5.9
CURRENT EMPLOYMENT
Full-Time
56.9
57.2
13.4
13.1
7.4
7.6
Part-Time
51.3a
55.4
13.5
15.4
8.4
9.8
Unemployed
64.9
59.2
21.1
23.3
13.5
13.1
Other1
33.6a
36.1
8.4
8.4
4.9
5.3
140320
Table 1.23A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
118,764a
121,664
37,011
37,304
21,486
22,376
GENDER
Male
63,530
64,356
21,526
21,431
13,395
13,451
Female
55,234a
57,308
15,485
15,873
8,091
8,926
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
103,769a
106,841
31,708
32,039
18,676
19,215
White
84,343
86,868
24,534
25,136
14,359
15,008
Black or African American
13,311
13,821
5,058
4,549
3,121
2,913
American Indian or Alaska Native
880
791
324
331
166
154
Native Hawaiian or Other Pacific Islander
*
383
179
158
75
*
Asian
2,796
2,670
882
829
448
362
Two or More Races
1,986
2,307
732a
1,036
508
670
Hispanic or Latino
14,995
14,823
5,303
5,264
2,810
3,161
EDUCATION
< High School
14,176a
12,958
6,064
5,453
3,786
3,799
High School Graduate
34,013
33,938
10,985
10,900
6,798
6,907
Some College
35,166
35,911
11,476
11,221
6,369
6,833
College Graduate
35,409b
38,856
8,486a
9,729
4,533
4,837
CURRENT EMPLOYMENT
Full-Time
67,447
68,604
18,603
18,537
10,482
10,799
Part-Time
17,524
18,792
6,819
7,446
4,106
4,613
Unemployed
8,729b
7,093
3,855
3,614
2,451
2,149
Other1
25,064a
27,176
7,734
7,707
4,448
4,815
140320
Table 1.23B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
50.5
51.2
15.7
15.7
9.1
9.4
GENDER
Male
56.1
56.2
19.0
18.7
11.8
11.8
Female
45.3
46.6
12.7
12.9
6.6
7.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
51.8
52.9
15.8
15.9
9.3
9.5
White
54.1a
55.6
15.7
16.1
9.2
9.6
Black or African American
49.0
49.7
18.6a
16.4
11.5
10.5
American Indian or Alaska Native
68.0
63.7
25.0
26.7
12.8
12.4
Native Hawaiian or Other Pacific Islander
*
49.6
18.2
20.5
7.6
*
Asian
24.1
22.1
7.6
6.8
3.9
3.0
Two or More Races
58.1
65.2
21.4a
29.3
14.9
19.0
Hispanic or Latino
43.1
41.5
15.2
14.7
8.1
8.9
EDUCATION
< High School
41.4
40.3
17.7
17.0
11.1
11.8
High School Graduate
48.8
48.5
15.8
15.6
9.8
9.9
Some College
56.2
56.6
18.3
17.7
10.2
10.8
College Graduate
51.6a
54.0
12.4
13.5
6.6
6.7
CURRENT EMPLOYMENT
Full-Time
57.3
57.7
15.8
15.6
8.9
9.1
Part-Time
53.5
55.7
20.8
22.1
12.5
13.7
Unemployed
64.3
60.1
28.4
30.6
18.1
18.2
Other1
35.2
37.2
10.9
10.6
6.3
6.6
140320
Table 1.24A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
111,239a
114,712
31,513
32,952
18,855
19,810
AGE
12-17
4,232
4,093
3,363
3,346
1,800
1,762
18-25
18,052
18,051
10,887
11,000
6,485
6,636
26 or Older
88,955b
92,568
17,263
18,606
10,571
11,412
GENDER
Male
60,056
61,743
19,193
19,713
12,085
12,300
Female
51,183
52,969
12,320
13,239
6,770
7,510
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
97,803b
101,254
27,026a
28,538
16,340
17,147
White
79,911a
82,425
20,778
21,984
12,468
13,168
Black or African American
12,549
13,241
4,413
4,433
2,800
2,727
American Indian or Alaska Native
710
722
235
275
136
151
Native Hawaiian or Other Pacific Islander
*
398
177
167
73
117
Asian
2,253
2,238
643
695
318
300
Two or More Races
1,978
2,229
779
985
545
684
Hispanic or Latino
13,435
13,459
4,488
4,414
2,515
2,663
140320
Table 1.24B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
42.8
43.7
12.1
12.6
7.3
7.5
AGE
12-17
17.0
16.4
13.5
13.4
7.2
7.1
18-25
52.2
51.9
31.5
31.6
18.7
19.1
26 or Older
44.4
45.7
8.6
9.2
5.3
5.6
GENDER
Male
47.7
48.6
15.2
15.5
9.6
9.7
Female
38.1
39.2
9.2
9.8
5.0
5.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
44.5a
45.8
12.3
12.9
7.4
7.8
White
47.1a
48.5
12.3
12.9
7.4
7.7
Black or African American
40.9
42.4
14.4
14.2
9.1
8.7
American Indian or Alaska Native
49.2
51.5
16.3
19.6
9.4
10.8
Native Hawaiian or Other Pacific Islander
*
45.7
16.4
19.2
6.8
13.4
Asian
17.6
16.8
5.0
5.2
2.5
2.2
Two or More Races
47.6
52.0
18.8
23.0
13.1
16.0
Hispanic or Latino
33.3
32.6
11.1
10.7
6.2
6.5
140320
Table 1.25A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
4,232
4,093
3,363
3,346
1,800
1,762
GENDER
Male
2,266
2,188
1,799
1,793
951
1,004
Female
1,966
1,905
1,565
1,554
849
758
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
3,202
3,141
2,613
2,596
1,430
1,361
White
2,320
2,192
1,924
1,836
1,036
971
Black or African American
619
640
477
506
264
255
American Indian or Alaska Native
29
44
23
32
13
15
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
*
Asian
54a
103
45a
88
21
45
Two or More Races
161
134
133
117
87
65
Hispanic or Latino
1,030
953
750
751
370
401
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic
1,239
1,169
1,028
986
552
546
Female, White, Not Hispanic
1,081
1,023
896
851
484
425
Male, Black, Not Hispanic
328
344
243
273
139
157
Female, Black, Not Hispanic
291
295
234
232
125
97
Male, Hispanic
553
524
408
417
191
230
Female, Hispanic
477
429
342
334
178
171
140320
Table 1.25B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
17.0
16.4
13.5
13.4
7.2
7.1
GENDER
Male
17.8
17.2
14.1
14.1
7.5
7.9
Female
16.1
15.6
12.8
12.8
7.0
6.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
16.5
16.2
13.4
13.4
7.4
7.0
White
16.9
16.1
14.0
13.5
7.5
7.1
Black or African American
17.5
18.6
13.5
14.7
7.5
7.4
American Indian or Alaska Native
19.7
27.8
15.2
20.1
8.5
9.1
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
*
Asian
4.6a
8.3
3.8a
7.1
1.8
3.6
Two or More Races
21.9
17.8
18.2
15.5
11.9
8.6
Hispanic or Latino
18.8
17.1
13.7
13.5
6.7
7.2
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic
17.6
16.8
14.6
14.2
7.8
7.8
Female, White, Not Hispanic
16.1
15.3
13.4
12.7
7.2
6.4
Male, Black, Not Hispanic
18.4
19.6
13.6
15.6
7.8
9.0
Female, Black, Not Hispanic
16.7
17.5
13.5
13.8
7.2
5.8
Male, Hispanic
19.7
18.4
14.5
14.7
6.8
8.1
Female, Hispanic
17.8
15.8
12.8
12.3
6.6
6.3
140320
Table 1.26A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
18,052
18,051
10,887
11,000
6,485
6,636
GENDER
Male
9,721
9,790
6,315
6,422
4,045
4,111
Female
8,332
8,260
4,573
4,577
2,440
2,525
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
14,744
14,611
9,027
9,076
5,412
5,472
White
11,019
10,953
6,589
6,737
3,870
4,142
Black or African American
2,465
2,436
1,633
1,575
1,084
936
American Indian or Alaska Native
171
129
92
72
42
36
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
37
Asian
527
542
337
347
168
144
Two or More Races
482
447
320
289
216
177
Hispanic or Latino
3,308
3,439
1,860
1,924
1,073
1,164
EDUCATION
< High School
2,749
2,844
1,794
1,887
1,194
1,269
High School Graduate
5,956
5,973
3,572
3,656
2,253
2,209
Some College
6,667
6,504
4,105
3,964
2,347
2,426
College Graduate
2,679
2,729
1,417
1,493
690
732
CURRENT EMPLOYMENT
Full-Time
7,423
7,613
3,951
4,128
2,392
2,421
Part-Time
5,006
4,963
3,282
3,318
1,945
2,044
Unemployed
2,398
2,356
1,630
1,667
1,026
1,037
Other1
3,225
3,118
2,025
1,887
1,121
1,134
140320
Table 1.26B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
52.2
51.9
31.5
31.6
18.7
19.1
GENDER
Male
56.0
56.1
36.4
36.8
23.3
23.5
Female
48.3
47.7
26.5
26.4
14.1
14.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
53.7
53.1
32.9
33.0
19.7
19.9
White
56.4
56.2
33.7
34.6
19.8a
21.2
Black or African American
50.2
48.7
33.3
31.5
22.1a
18.7
American Indian or Alaska Native
64.4
56.3
34.5
31.5
15.8
15.7
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
18.2
Asian
29.6
29.0
18.9
18.5
9.4
7.7
Two or More Races
63.3
61.0
42.0
39.5
28.4
24.2
Hispanic or Latino
46.3
47.4
26.0
26.5
15.0
16.1
EDUCATION
< High School
51.7
50.9
33.7
33.8
22.4
22.7
High School Graduate
50.5
49.9
30.3
30.5
19.1
18.5
Some College
54.0
53.4
33.2
32.5
19.0
19.9
College Graduate
52.2
54.1
27.6
29.6
13.5
14.5
CURRENT EMPLOYMENT
Full-Time
55.1
56.3
29.3
30.5
17.8
17.9
Part-Time
53.3
51.3
34.9
34.3
20.7
21.1
Unemployed
58.4
56.7
39.7
40.1
25.0
24.9
Other1
42.3
41.9
26.6
25.3
14.7
15.2
140320
Table 1.27A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
88,955b
92,568
17,263
18,606
10,571
11,412
GENDER
Male
48,069
49,764
11,080
11,497
7,089
7,185
Female
40,886a
42,804
6,183a
7,108
3,482a
4,227
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
79,858b
83,502
15,385a
16,867
9,498
10,314
White
66,571
69,280
12,265
13,411
7,562
8,055
Black or African American
9,465
10,165
2,303
2,352
1,452
1,537
American Indian or Alaska Native
509
548
120
170
81
100
Native Hawaiian or Other Pacific Islander
*
*
*
*
32
*
Asian
1,672
1,594
260
259
130
111
Two or More Races
1,335
1,648
326a
579
242
442
Hispanic or Latino
9,097
9,067
1,878
1,739
1,073
1,098
EDUCATION
< High School
9,101
8,402
2,838
2,394
1,902
1,705
High School Graduate
24,866
24,969
4,926
5,103
3,227
3,427
Some College
25,531
26,538
4,512
5,044
2,747
3,206
College Graduate
29,457b
32,660
4,987a
6,064
2,694
3,075
CURRENT EMPLOYMENT
Full-Time
54,093
55,692
9,686
10,576
5,749
6,467
Part-Time
10,812a
12,099
2,246a
2,826
1,402a
1,876
Unemployed
5,695b
4,263
1,569
1,392
972
731
Other1
18,355a
20,514
3,762
3,812
2,447
2,338
140320
Table 1.27B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
44.4
45.7
8.6
9.2
5.3
5.6
GENDER
Male
50.2
51.3
11.6
11.9
7.4
7.4
Female
39.0
40.5
5.9a
6.7
3.3a
4.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
46.2a
47.9
8.9a
9.7
5.5
5.9
White
48.8a
50.6
9.0
9.8
5.5
5.9
Black or African American
42.5
44.6
10.3
10.3
6.5
6.7
American Indian or Alaska Native
49.5
54.2
11.7
16.8
7.9
9.9
Native Hawaiian or Other Pacific Islander
*
*
*
*
4.0
*
Asian
17.0
15.6
2.7
2.5
1.3
1.1
Two or More Races
50.2
58.8
12.3a
20.6
9.1
15.8
Hispanic or Latino
32.9
31.9
6.8
6.1
3.9
3.9
EDUCATION
< High School
31.5
31.6
9.8
9.0
6.6
6.4
High School Graduate
42.9
43.0
8.5
8.8
5.6
5.9
Some College
50.8
51.8
9.0
9.8
5.5
6.3
College Graduate
46.4a
48.8
7.9
9.1
4.2
4.6
CURRENT EMPLOYMENT
Full-Time
51.9
52.8
9.3
10.0
5.5
6.1
Part-Time
46.3a
50.2
9.6
11.7
6.0
7.8
Unemployed
60.1
55.7
16.6
18.2
10.3
9.6
Other1
28.9a
31.3
5.9
5.8
3.9
3.6
140320
Table 1.28A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
107,007b
110,619
28,150
29,606
17,055
18,048
GENDER
Male
57,790
59,555
17,394
17,920
11,134
11,296
Female
49,217a
51,064
10,756a
11,686
5,922a
6,752
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
94,601b
98,113
24,412a
25,942
14,910
15,786
White
77,590
80,233
18,854
20,148
11,431
12,197
Black or African American
11,931
12,601
3,936
3,927
2,536
2,473
American Indian or Alaska Native
680
678
212
243
123
136
Native Hawaiian or Other Pacific Islander
*
370
166
*
65
*
Asian
2,199
2,136
598
606
297
256
Two or More Races
1,817
2,095
646
868
458
620
Hispanic or Latino
12,405
12,506
3,738
3,663
2,145
2,262
EDUCATION
< High School
11,850
11,247
4,631
4,281
3,096
2,974
High School Graduate
30,823
30,941
8,498
8,759
5,480
5,636
Some College
32,198
33,042
8,616
9,008
5,095
5,632
College Graduate
32,136b
35,389
6,404a
7,557
3,384
3,806
CURRENT EMPLOYMENT
Full-Time
61,516
63,305
13,637
14,704
8,141
8,889
Part-Time
15,818
17,062
5,528
6,144
3,347a
3,920
Unemployed
8,093b
6,620
3,199
3,058
1,998
1,768
Other1
21,580a
23,632
5,786
5,699
3,569
3,472
140320
Table 1.28B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
45.5
46.6
12.0
12.5
7.3
7.6
GENDER
Male
51.1
52.1
15.4
15.7
9.8
9.9
Female
40.4
41.5
8.8
9.5
4.9a
5.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
47.2a
48.6
12.2
12.9
7.4
7.8
White
49.8a
51.3
12.1
12.9
7.3
7.8
Black or African American
43.9
45.3
14.5
14.1
9.3
8.9
American Indian or Alaska Native
52.6
54.6
16.4
19.5
9.5
11.0
Native Hawaiian or Other Pacific Islander
*
47.8
16.9
*
6.6
*
Asian
19.0
17.6
5.2
5.0
2.6
2.1
Two or More Races
53.1
59.3
18.9
24.5
13.4
17.5
Hispanic or Latino
35.6
35.0
10.7
10.3
6.2
6.3
EDUCATION
< High School
34.6
35.0
13.5
13.3
9.0
9.2
High School Graduate
44.2
44.2
12.2
12.5
7.9
8.1
Some College
51.5
52.1
13.8
14.2
8.1
8.9
College Graduate
46.9a
49.2
9.3
10.5
4.9
5.3
CURRENT EMPLOYMENT
Full-Time
52.3
53.2
11.6
12.4
6.9
7.5
Part-Time
48.3
50.6
16.9
18.2
10.2
11.6
Unemployed
59.6
56.1
23.6
25.9
14.7
15.0
Other1
30.3
32.4
8.1
7.8
5.0
4.8
140320
Table 1.29A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
37,688
37,634
4,671
4,182
1,650
1,549
AGE
12-17
265
215
180a
131
30
43
18-25
4,267
4,041
1,600
1,543
398
398
26 or Older
33,156
33,378
2,890
2,508
1,222
1,108
GENDER
Male
22,757
22,612
3,298
2,855
1,231
1,038
Female
14,931
15,022
1,372
1,327
419
511
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
33,030
32,901
4,005
3,520
1,481
1,313
White
28,583
28,674
3,160
2,961
1,009
1,036
Black or African American
2,978
2,748
552
401
336
246
American Indian or Alaska Native
286
197
37
16
24
1
Native Hawaiian or Other Pacific Islander
71
*
*
13
2
*
Asian
507
383
98
77
58
17
Two or More Races
605
752
123a
53
52
10
Hispanic or Latino
4,658
4,733
666
662
169
236
140320
Table 1.29B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
14.5
14.3
1.8
1.6
0.6
0.6
AGE
12-17
1.1
0.9
0.7a
0.5
0.1
0.2
18-25
12.3
11.6
4.6
4.4
1.1
1.1
26 or Older
16.5
16.5
1.4
1.2
0.6
0.5
GENDER
Male
18.1
17.8
2.6
2.2
1.0
0.8
Female
11.1
11.1
1.0
1.0
0.3
0.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
15.0
14.9
1.8
1.6
0.7
0.6
White
16.9
16.9
1.9
1.7
0.6
0.6
Black or African American
9.7
8.8
1.8
1.3
1.1
0.8
American Indian or Alaska Native
19.8
14.0
2.6
1.1
1.6
0.1
Native Hawaiian or Other Pacific Islander
6.6
*
*
1.5
0.2
*
Asian
4.0
2.9
0.8
0.6
0.5
0.1
Two or More Races
14.6
17.5
3.0a
1.2
1.2
0.2
Hispanic or Latino
11.6
11.5
1.7
1.6
0.4
0.6
140320
Table 1.30A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
265
215
180a
131
30
43
GENDER
Male
129
121
88
74
13
19
Female
136a
94
92a
58
17
24
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
172
145
129
96
25
29
White
140
132
105
86
19
25
Black or African American
12
4
9
4
3
4
American Indian or Alaska Native
*
0
*
*
0
*
Native Hawaiian or Other Pacific Islander
*
2
*
*
*
*
Asian
5
1
3
*
*
*
Two or More Races
14
6
10
5
3
*
Hispanic or Latino
93
70
51
35
5a
14
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic
52
70
41
47
5
9
Female, White, Not Hispanic
87
62
63
40
14
16
Male, Black, Not Hispanic
7
4
7
4
1
4
Female, Black, Not Hispanic
5
0
2
0
2
*
Male, Hispanic
55
45
28
21
5
7
Female, Hispanic
37
25
24
14
*
8
140320
Table 1.30B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
1.1
0.9
0.7a
0.5
0.1
0.2
GENDER
Male
1.0
1.0
0.7
0.6
0.1
0.2
Female
1.1a
0.8
0.8a
0.5
0.1
0.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
0.9
0.8
0.7
0.5
0.1
0.2
White
1.0
1.0
0.8
0.6
0.1
0.2
Black or African American
0.4
0.1
0.3
0.1
0.1
0.1
American Indian or Alaska Native
*
0.3
*
*
0.1
*
Native Hawaiian or Other Pacific Islander
*
1.6
*
*
*
*
Asian
0.4
0.1
0.3
*
*
*
Two or More Races
1.9
0.9
1.4
0.6
0.4
*
Hispanic or Latino
1.7
1.3
0.9
0.6
0.1a
0.3
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic
0.7
1.0
0.6
0.7
0.1
0.1
Female, White, Not Hispanic
1.3
0.9
0.9
0.6
0.2
0.2
Male, Black, Not Hispanic
0.4
0.2
0.4
0.2
0.1
0.2
Female, Black, Not Hispanic
0.3
0.0
0.1
0.0
0.1
*
Male, Hispanic
2.0
1.6
1.0
0.7
0.2
0.2
Female, Hispanic
1.4
0.9
0.9
0.5
*
0.3
140320
Table 1.31A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
4,267
4,041
1,600
1,543
398
398
GENDER
Male
2,532
2,408
1,046
994
266
263
Female
1,735
1,633
554
549
132
134
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
3,398
3,189
1,274
1,267
322
322
White
3,004
2,845
1,114
1,143
269
284
Black or African American
144
106
61
47
17
23
American Indian or Alaska Native
50
25
15
8
3
1
Native Hawaiian or Other Pacific Islander
*
15
*
*
*
*
Asian
67
84
31
29
15
6
Two or More Races
117
113
44
33
17
5
Hispanic or Latino
869
852
326
276
76
76
EDUCATION
< High School
775
725
255
215
69
54
High School Graduate
1,469
1,300
561
454
158
131
Some College
1,444
1,365
558
566
125
147
College Graduate
579
651
227
308
46
66
CURRENT EMPLOYMENT
Full-Time
1,957
1,914
629
701
152
183
Part-Time
1,097
981
469
448
104
121
Unemployed
579
522
255a
169
81b
32
Other1
635
624
248
225
61
62
140320
Table 1.31B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
12.3
11.6
4.6
4.4
1.1
1.1
GENDER
Male
14.6
13.8
6.0
5.7
1.5
1.5
Female
10.1
9.4
3.2
3.2
0.8
0.8
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
12.4
11.6
4.6
4.6
1.2
1.2
White
15.4
14.6
5.7
5.9
1.4
1.5
Black or African American
2.9
2.1
1.2
0.9
0.3
0.5
American Indian or Alaska Native
18.7
11.1
5.5
3.6
1.1
0.6
Native Hawaiian or Other Pacific Islander
*
7.7
*
*
*
*
Asian
3.8
4.5
1.7
1.6
0.8
0.3
Two or More Races
15.4
15.4
5.7
4.6
2.2
0.6
Hispanic or Latino
12.2
11.8
4.6
3.8
1.1
1.1
EDUCATION
< High School
14.6
13.0
4.8
3.9
1.3
1.0
High School Graduate
12.5a
10.9
4.8a
3.8
1.3
1.1
Some College
11.7
11.2
4.5
4.6
1.0
1.2
College Graduate
11.3
12.9
4.4a
6.1
0.9
1.3
CURRENT EMPLOYMENT
Full-Time
14.5
14.2
4.7
5.2
1.1
1.4
Part-Time
11.7
10.2
5.0
4.6
1.1
1.2
Unemployed
14.1
12.6
6.2a
4.1
2.0b
0.8
Other1
8.3
8.4
3.3
3.0
0.8
0.8
140320
Table 1.32A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
33,156
33,378
2,890
2,508
1,222
1,108
GENDER
Male
20,096
20,083
2,165
1,788
952
756
Female
13,060
13,295
726
720
270
352
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
29,460
29,566
2,603
2,156
1,133
962
White
25,440
25,697
1,942
1,731
721
727
Black or African American
2,822
2,637
482
350
316
219
American Indian or Alaska Native
235
171
*
8
*
*
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
*
Asian
435
298
64
48
44
10
Two or More Races
474
632
70a
14
32
5
Hispanic or Latino
3,696
3,811
288
351
89
145
EDUCATION
< High School
4,342
3,861
684a
386
354
220
High School Graduate
9,660
9,139
850a
569
313
256
Some College
9,768
9,868
666
818
316
356
College Graduate
9,386
10,510
691
734
239
276
CURRENT EMPLOYMENT
Full-Time
20,266
19,922
1,609
1,260
633a
396
Part-Time
4,217
4,881
353
418
155
237
Unemployed
2,380b
1,722
423a
243
186
109
Other1
6,293
6,853
505
586
248
365
140320
Table 1.32B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
16.5
16.5
1.4
1.2
0.6
0.5
GENDER
Male
21.0
20.7
2.3
1.8
1.0
0.8
Female
12.5
12.6
0.7
0.7
0.3
0.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
17.0
17.0
1.5
1.2
0.7
0.6
White
18.7
18.8
1.4
1.3
0.5
0.5
Black or African American
12.7
11.6
2.2
1.5
1.4
1.0
American Indian or Alaska Native
22.9
16.9
*
0.7
*
*
Native Hawaiian or Other Pacific Islander
*
*
*
*
*
*
Asian
4.4
2.9
0.7
0.5
0.4
0.1
Two or More Races
17.8
22.5
2.6a
0.5
1.2
0.2
Hispanic or Latino
13.4
13.4
1.0
1.2
0.3
0.5
EDUCATION
< High School
15.0
14.5
2.4a
1.5
1.2
0.8
High School Graduate
16.7
15.8
1.5a
1.0
0.5
0.4
Some College
19.4
19.3
1.3
1.6
0.6
0.7
College Graduate
14.8
15.7
1.1
1.1
0.4
0.4
CURRENT EMPLOYMENT
Full-Time
19.5
18.9
1.5
1.2
0.6a
0.4
Part-Time
18.0
20.3
1.5
1.7
0.7
1.0
Unemployed
25.1
22.5
4.5
3.2
2.0
1.4
Other1
9.9
10.5
0.8
0.9
0.4
0.6
140320
Table 1.33A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic
Lifetime (2012)
Lifetime (2013)
Past Year (2012)
Past Year (2013)
Past Month (2012)
Past Month (2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack. a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level. b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level. 1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL
37,423
37,419
4,491
4,051
1,620
1,505
GENDER
Male
22,628
22,491
3,211
2,781
1,218
1,019
Female
14,795
14,928
1,280
1,269
402
487
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino
32,858
32,755
3,876
3,424
1,456
1,284
White
28,444
28,542
3,055
2,874
989
1,011
Black or African American
2,965
2,744
543
397
333
242
American Indian or Alaska Native
285
196
35
16
24
1
Native Hawaiian or Other Pacific Islander
71
*
*
11
2
*
Asian
503
382
94
77
58
17
Two or More Races
591
745
113a
48
49
10
Hispanic or Latino
4,565
4,663
614
627
164
222
EDUCATION
< High School
5,118
4,586
939b
602
422
274
High School Graduate
11,128
10,439
1,411b
1,023
471
387
Some College
11,212
11,233
1,223
1,384
441
503
College Graduate
9,965
11,161
918
1,042
286
341
CURRENT EMPLOYMENT
Full-Time
22,223
21,835
2,238
1,961
785
579
Part-Time
5,314
5,862
822
866
259
358
Unemployed
2,959b
2,244
678b
412
267a
142
Other1
6,928
7,477
753
811
309
427
140320
Table 1.33B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2012 and 2013